| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
SANUWAVE Health, Inc.$6.83
-0.44 (-6.12%)
F 17Pipeline Score MedTech · Clinical
Market Cap
143.52 M
EPS
1.87
P/E Ratio
51.06 $
Value Trade
1.12 M
SEC Financials
Q1 2026Dilution Risk
Revenue
9.62 M
R&D Expenses
660.00 K
Operating CF
397.00 K
Total Assets
37.10 M
Total Liabilities
35.26 M
Equity
1.84 M
D/E Ratio
12,345
-2.28 %
Week
-13.16 %
1 Month
-32.54 %
3 Month
-47.45 %
6 Month
-99.92 %
5 Year
-100 %
All Time
Cash Data
Cash Position
10.78 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 12, 2026
Overview
Volume
585.81 K
52 Week Range
15.36 - 46.59
% held by Insiders
5.42 %
% held by Institutions
57.59 %
Enterprise Value
154.90 M
Total Shares
8.60 M
Short %
7.76 %
Float Shares
7.46 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
F17
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 15%
Micro Cap (rank 776 of 912)
Percentile RankSANUWAVE Health, Inc. has significant pipeline risk (17/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
dermaPACE | Diabetic Foot Ulcers | Phase 3 | 2016-03-24 | 35.47% vs. 24.39%; p=0.027 at 20 weeks; 37.79% vs. 26.22%; p=0.023 at 24 weeks; 22.67% vs. 18.29%; p=0.320 at 12 weeks; 1.92cm2 versus 0.16cm2; p=0.047 at 24 weeks; 18.0% versus 31.1%; p=0.005 at 12 weeks; 25.6% versus 34.2%; p=0.086 at 24 weeks; 2.3% vs. 3.0%; p=0.745 Read More | SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers Read More | |
dermaPACE | Diabetic Foot Ulcers | Phase 3 | 2016-03-24 | 35.47% vs. 24.39%; p=0.027 at 20 weeks; 37.79% vs. 26.22%; p=0.023 at 24 weeks; 22.67% vs. 18.29%; p=0.320 at 12 weeks; 1.92cm2 versus 0.16cm2; p=0.047 at 24 weeks; 18.0% versus 31.1%; p=0.005 at 12 weeks; 25.6% versus 34.2%; p=0.086 at 24 weeks; 2.3% vs. 3.0%; p=0.745 Read More | SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers Read More | |
dermaPACE | Diabetic Foot Ulcers | Phase 3 | 2016-03-24 | 35.47% vs. 24.39%; p=0.027 at 20 weeks; 37.79% vs. 26.22%; p=0.023 at 24 weeks; 22.67% vs. 18.29%; p=0.320 at 12 weeks; 1.92cm2 versus 0.16cm2; p=0.047 at 24 weeks; 18.0% versus 31.1%; p=0.005 at 12 weeks; 25.6% versus 34.2%; p=0.086 at 24 weeks; 2.3% vs. 3.0%; p=0.745 Read More | SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers Read More |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SNWV
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SNWV Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SNWV▲ +6.2%on this news· ran to -35% by day 1
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
Sanuwave Health reported preliminary revenues for Q2 2026 between $9.6 and $9.8 million, surpassing its revised guidance. Despite a 3-5% decrease from the previous year, record sales of consumable applicators suggest growing confidence in their Ultramist technology. The company is also addressing challenges in capital sales through a trade-in program for used systems.
Read more →SNWV▼ -42%on this news
Sanuwave Health Updates Second Quarter 2026 Guidance
Sanuwave Health has updated its revenue guidance for Q2 2026 to between $8.5 and $9.5 million, reflecting a decline from earlier projections. The company faces market disruptions affecting sales of its Ultramist system due to reimbursement clawbacks. Despite these challenges, Sanuwave reports strong applicator sales and remains optimistic about its product pipeline.
Read more →SNWV▲ +18.1%on this news
Sanuwave Announces Revenues and Financial Results for Q1 FY2026
Sanuwave Health reported Q1 2026 revenues of $9.6 million, marking a 3.1% increase from the previous year, and the highest Q1 revenues in its history. Despite a GAAP operating loss of $1.1 million, the company anticipates a 10-15% revenue growth for Q2 2026. CEO Morgan Frank noted a recovery in sales, particularly in applicator sales, and expressed optimism for continued growth throughout 2026.
Read more →SNWVSanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
Sanuwave Health, Inc. has announced it will hold a conference call on May 13, 2026, at 8:30 AM (ET) to discuss its Q1 2026 financial results. The call will provide investors with insights into the company's financial performance, alongside the details available on their website. Sanuwave focuses on developing and commercializing advanced non-invasive medical systems aimed at wound care and tissue regeneration. However, investors are cautioned regarding forward-looking statements as they involve risks that could affect actual results.
Read more →SNWVSanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
Sanuwave Health has reported preliminary revenues for Q1 2026 ranging from $9.6 million to $9.7 million, representing a 3-4% increase year-over-year. The results align with previous financial guidance, though the revenue came in at the lower end of expectations due to delayed deals. CEO Morgan Frank expressed optimism about the company’s Ultramist product and noted increased interest from practitioners at a recent conference. However, the market is experiencing challenges related to changes in reimbursement policies, prompting a cautious approach from some healthcare providers.
Read more →SNWVSanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6-$9.7 Million, Up 3-4% Year-over-Year Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended
Sanuwave Health has reported preliminary revenues for Q1 2026 in the range of $9.6 to $9.7 million, marking a 3-4% increase from the same period last year. This figure aligns with previously set guidance, although the CEO noted that some anticipated deals did not close in the quarter. Factors such as changes in reimbursement policies for wound care products have caused market hesitancy among practitioners. Despite these challenges, interest in Sanuwave's offerings remains high, as evidenced by strong engagement at recent industry conferences.
Read more →SNWVSanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
Sanuwave Health, Inc. reported record revenues of $13.4 million for Q4 2025, marking a 29.7% increase from the previous year. The full year revenue reached $44.1 million, up 35.0% from 2024. Despite challenges in the wound care sector, the company anticipates continued growth with guidance for Q1 2026 revenues between $9.6 and $10.3 million. The CEO highlighted the potential for their UltraMIST product amidst industry changes.
Read more →SNWVSanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
Sanuwave Health, Inc. will hold a conference call on March 27, 2026, to discuss its financial results for Q4 and the full year of 2025. This announcement highlights the company's ongoing focus on developing and commercializing advanced wound care products. Participants can access the call via telephone or through a dedicated online link. A replay of the call will be available afterward for those who cannot attend the live event.
Read more →SNWVSanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
Sanuwave Health announced preliminary revenues of $13.3 to $13.4 million for Q4 2025, marking a 29%-30% increase from Q4 2024. The full-year revenue for 2025 reached $44.3-$44.4 million, a 36% increase compared to the previous year. The company attributed its success to strategic adaptations in the evolving wound care market, positioning itself for future opportunities.
Read more →SNWVSanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Sanuwave Health, Inc. will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12 to January 15, 2026. The company aims to connect with investors during the event. Sanuwave focuses on developing FDA-approved wound care products and regenerative medicine technologies.
Read more →SNWV▼ -8.6%on this newsshared move
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
Sanuwave Health has announced the addition of its UltraMIST product line to Healogics' iSupply Group Purchasing Organization. This collaboration allows iSupply members, including various healthcare facilities, to access UltraMIST, which is expected to be rolled out by the end of 2025. The partnership aims to provide innovative wound care solutions and enhance patient care.
Read more →SNWV▲ +17.7%on this news· ran to +30% by day 1
Sanuwave Announces Q3 FY2025 Financial Results
Sanuwave Health, Inc. reported Q3 2025 revenues of $11.5 million, a 22% increase from the previous year, marking the highest quarterly revenue in its history. The gross margin improved to 77.9%, although GAAP operating income decreased to $1.5 million due to stock-based compensation costs. The company anticipates Q4 2025 revenues between $13-$14 million despite industry challenges related to reimbursement changes.
Read more →SNWV▲ +17.7%on this news· ran to +30% by day 1shared move
Sanuwave Announces Q3 FY2025 Financial Results Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2025. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%,
Sanuwave Health, Inc. reported its financial results for Q3 FY2025, showing revenues of $11.5 million, a 22% increase compared to the same period last year. This follows the highest quarterly growth in company history, with 155 UltraMist systems sold, setting a record. However, the company experienced a decrease in GAAP Operating Income from the previous year. Despite some uncertainty in the market regarding reimbursement changes, the CEO maintains a positive outlook for future growth, forecasting revenues of $13-$14 million for Q4 2025.
Read more →SNWVSanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
Sanuwave Health, Inc. will conduct a conference call on November 7, 2025, at 8:30 AM (ET) to discuss its Q3 2025 financial results. The call will be accessible via telephone and a link for instant access is provided. Sanuwave specializes in FDA-approved wound care products and aims to improve healing processes through its innovative technologies.
Read more →SNWV▼ -5.3%on this newsshared move
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)
Sanuwave Health, Inc. announced that the final rule for the 2026 Physician Fee Schedule by CMS maintains reimbursement rates for the UltraMIST procedure (CPT code 97610) largely unchanged from 2025. The company expects slight increases in reimbursement for many providers, aligning with their prior expectations. CEO Morgan Frank emphasized the stability of these rates amidst changes in other wound care reimbursements.
Read more →SNWV▼ -21.6%on this news
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
Sanuwave Health announced preliminary revenues of $11.4 to $11.6 million for Q3 2025, marking the highest quarterly revenue in its history. This represents a 22-24% increase compared to Q3 2024, although it fell short of earlier guidance. The CEO noted challenges in the wound care market due to reimbursement uncertainties, leading to delayed purchasing decisions. Despite these challenges, the company recorded a significant number of system sales and plans to adjust its annual revenue guidance.
Read more →SNWVSanuwave Announces Strategic Debt Refinancing with New Credit Facility
Sanuwave Health, Inc. has announced a strategic refinancing of its debt through a new credit facility from J.P. Morgan. The $23 million term loan and $5 million revolving credit facility will help repay the existing NH Expansion debt. This move is expected to improve the company's financial position and cash flow management.
Read more →SNWVDocument Sanuwave Announces Strategic Debt Refinancing with New Credit Facility Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed
Sanuwave Health, Inc. has successfully refinanced its $27.5 million debt facility with a new credit facility from J.P. Morgan, comprising a $23 million term loan and a $5 million revolving credit facility. The company used the refinancing proceeds to repay the NH Expansion debt and associated costs, reducing its overall debt burden. The new agreement offers more favorable interest rates and the absence of prepayment penalties, positioning Sanuwave to improve cash flow and enhance financial stability. CEO Morgan Frank expressed optimism about the partnership with J.P. Morgan going forward.
Read more →SNWV▲ +15.9%on this news
Sanuwave Announces Q2 FY2025 Financial Results
Sanuwave Health, Inc. announced its financial results for Q2 FY2025, reporting revenues of $10.2 million, up 42% from $7.2 million in Q2 FY2024. The company's gross margin improved to 78.3%, and it achieved a net income of $1.1 million, though this was lower than the prior year's Q2 results that included a substantial gain on debt extinguishment. Additionally, the company provided guidance for revenue for Q3 2025 of $12-$12.7 million, indicating an optimistic outlook as it refines its sales and marketing efforts.
Read more →SNWV▲ +15.9%on this news
Sanuwave Announces Q2 FY2025 Financial Results Q2 2025 revenues were $10.2 million, up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 gross margin was 78.3
Sanuwave Health, Inc. reported its Q2 FY2025 financial results, showcasing a 42% increase in revenues to $10.2 million, marking the highest quarterly revenues in the company's history. The gross margin improved to 78.3%, up from 73.2% in the same quarter last year. Despite the positive revenue trends, the company's GAAP operating income and net income fell compared to Q2 2024 due to increased expenses and a lack of significant one-time gains. Sanuwave forecasts revenues of $12-$12.7 million for Q3 2025, reiterating its full-year revenue guidance of $48-$50 million.
Read more →SNWVSanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
Sanuwave Health, Inc. has announced a conference call scheduled for August 8, 2025, at 8:30 AM (ET) to present its financial results for Q2 2025. The firm specializes in FDA-approved wound care products and regenerative medicine. Interested parties can join the call via telephone or online, with materials available on their investor website. A replay of the call will be accessible until August 29, 2025.
Read more →SNWVSanuwave Health to Present at Canaccord Genuity Growth Conference
Sanuwave Health, Inc. will present at the 45th Annual Canaccord Genuity Growth Conference on August 13, 2025. CEO Morgan Frank will lead the presentation and is available for one-on-one investor meetings. The company specializes in FDA-approved wound care products and regenerative medicine technologies.
Read more →SNWVSanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
Sanuwave Health, Inc. announced preliminary revenues of $10.1 to $10.2 million for the second quarter of 2025, marking the highest quarterly revenue in the company's history. This represents a significant increase of 41% to 42% compared to the same quarter in 2024. The company highlights a successful transition period with new leadership in sales and operations, and anticipates continued growth. Full Q2 results are expected to be released on or around August 8, 2025.
Read more →SNWV▲ +9.7%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended
SANUWAVE Health reported preliminary revenue results for Q2 2025, projecting revenues between $10.1 million and $10.2 million, marking the highest quarterly revenue in the company's history. This represents a 41% to 42% increase from the same period in the previous year, with the first half of 2025 showing a significant revenue rise of 50-51%. CEO Morgan Frank noted that the company has been undergoing a significant transition, staffing up and optimizing their sales operations to better capture market opportunities. Detailed quarterly performance and future plans will be provided in their full Q2 results, expected around August 8, 2025.
Read more →SNWV▲ +7.9%on this news
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
Sanuwave Health has appointed Dustin Libby as Executive Vice President of Commercial Operations. Libby, with two decades of experience in the medical device industry, previously scaled a surgical business from $15M to over $500M in revenue. His expertise is expected to enhance Sanuwave's growth in the wound care market.
Read more →SNWVSanuwave Health Appoints Greg Bazar to Board of Directors
Sanuwave Health has appointed Greg Bazar to its Board of Directors, bringing extensive experience in engineering, technology, and cybersecurity. Bazar's diverse background is expected to enhance the company's strategic direction as it aims to innovate in wound care solutions. Meanwhile, long-time board member Michael Stolarski is stepping down but will continue to support the company in a consulting role. This leadership change comes as Sanuwave continues to focus on advancing its patented medical systems for healing across various conditions.
Read more →SNWVSanuwave Health Selected for Inclusion in Russell 2000 Index
Sanuwave Health, Inc. has announced its inclusion in the Russell 2000 Index as part of the 2025 Russell indexes reconstitution, effective June 30, 2025. The company will also be included in the Russell 3000 and Russell Microcap indices. These memberships, determined by market capitalization, are significant as they enhance investment visibility and are utilized by many investment managers for benchmarking. Sanuwave specializes in non-invasive wound care solutions and regenerative medicine products.
Read more →SNWVSanuwave Announces Q1 FY2025 Financial Results Q1 2025 revenues were $9.3 million, up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0%
Sanuwave Health, Inc. announced its financial results for Q1 FY2025, reporting revenues of $9.3 million, a 61% increase from $5.8 million in Q1 FY2024, marking the company's highest quarterly revenues for a first quarter. The gross margin for the quarter improved to 79.0%. Sanuwave sold 98 UltraMist systems in Q1 2025, a significant rise from 43 systems sold in the same quarter last year, although sales were lower than in Q4 2024. Despite a net loss of $5.7 million, the company provided an optimistic revenue growth forecast for Q2 2025, expecting an increase of 40-50% compared to the prior year.
Read more →SNWVSanuwave Announces Q1 FY2025 Financial Results
Sanuwave Health, Inc. announced strong Q1 FY2025 financial results, reporting revenues of $9.3 million, a 61% increase year-over-year, and the highest Q1 in the company's history. The gross margin rose to 79%, and the company experienced an increase in operating income of $2.0 million compared to the same period last year. Despite these positive metrics, Sanuwave reported a net loss of $5.7 million, impacted by the change in fair value of derivative liabilities. The company forecasts revenue growth of 40-50% for Q2 2025, reflecting continued positive expectations for the upcoming quarter.
Read more →SNWVSanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
Sanuwave Health, Inc. is set to host a conference call on May 9, 2025, at 8:30 AM (ET) to present its financial results for Q1 2025. This event underscores the company's commitment to transparency with its investors as it continues its work in the wound care sector. Sanuwave focuses on developing non-invasive medical systems that aid in healing processes across various conditions. The call's access information and replay details have been provided for investor convenience.
Read more →SNWVSANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
SANUWAVE Health has reported preliminary revenue results for the first quarter of 2025, projecting revenues between $9.1 million and $9.3 million, marking the highest first quarter revenues in the company's history. This figure represents an increase of 57% to 61% compared to the same period in 2024, largely driven by a significant rise in UltraMIST sales, which accounted for nearly all total revenues. The company's CEO expressed optimism about the strong start to 2025 and the robustness of their pipeline, while also noting strategic changes within their sales force. Full Q1 results are expected to be released by May 9, 2025.
Read more →SNWVDocument SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended
SANUWAVE Health announced preliminary revenue results for Q1 2025, reporting earnings between $9.1 million and $9.3 million. This marks the highest quarterly revenue recorded for the company in its history, showing an increase of 57% to 61% from the same quarter in 2024. Notably, UltraMIST's revenue accounted for nearly all of the total revenues, growing by over 65%. The CEO highlighted a successful transition in sales leadership and anticipates 2025 to be a breakout year.
Read more →SNWV▲ +17.5%on this news
SANUWAVE Announces Record Quarterly Revenues Q4 FY2024 Financial Results Q4 2024 revenues were $10.3 million , up 47% from Q4 2023. This was an all-time quarterly record for the Company. Full year 2024 revenues were $32.
SANUWAVE Health, Inc. reported record financial results for Q4 2024, with revenues reaching $10.3 million, marking a 47% increase year-over-year. The company's full-year revenues also set a record at $32.6 million, up 60% from 2023. Despite these achievements, SANUWAVE experienced a net loss of $12.7 million in Q4 2024, driven by changes in fair value of derivative liabilities. Looking ahead, SANUWAVE projects a strong revenue increase of 45-55% for Q1 2025, reflecting confidence in their growth strategy.
Read more →SNWV▼ -7.9%on this news
Document Sanuwave Health to Uplist to the Nasdaq Global Market Trading Under the Ticker "SNWV" Expected to Begin on
Sanuwave Health, a provider of advanced wound care products, has announced its uplisting to the Nasdaq Global Market under the ticker "SNWV". Trading is anticipated to start on March 7, 2025, and the company's stock will continue to be available on the OTCQB until then. The CEO highlighted the significant progress made by the company over the past 18 months and emphasized the company's commitment to transforming the wound care market. This uplisting is viewed as a crucial step toward enhancing shareholder value.
Read more →SNWVSanuwave Health to Uplist to the Nasdaq Global Market
Sanuwave Health, Inc. has announced the approval of its common stock for listing on the Nasdaq Global Market, with trading set to begin on March 7, 2025. This uplisting is viewed as a significant milestone, highlighting the company's progress over the last 18 months. CEO Morgan Frank expressed excitement about joining one of the world's premier stock exchanges and emphasized the firm's commitment to transforming the wound care market. The company's patented medical systems focus on enhancing the body's natural healing processes for various medical applications.
Read more →SNWVSANUWAVE Health to Participate in 37th Annual Roth Conference
SANUWAVE Health, Inc. has announced its participation in the 37th Annual Roth Conference taking place from March 16-18 in Dana Point, California. CEO Morgan Frank will be available for one-on-one meetings with interested investors during the conference. This event is significant in the small-cap sector, allowing companies to showcase their offerings and connect with potential investors.
Read more →SNWVSANUWAVE Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended
SANUWAVE Health, Inc. announced preliminary revenues for the fourth quarter of 2024, reporting between $10.1 million and $10.3 million, marking the highest quarterly revenue in the company's history. This represents a significant increase of 44% to 47% compared to the fourth quarter of 2023. UltraMist, a key product, generated over 54% of the company's total revenues during this period. The full financial results for Q4 and the entire year are expected to be released around the third week of March 2025.
Read more →SNWV▲ +74.6%on this news
SANUWAVE Announces Record Quarterly Revenues Q3 FY2024 Financial Results Q3 2024 revenues were $9.4 million , up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs
SANUWAVE Health, Inc. reported its financial results for Q3 FY2024, highlighting revenues of $9.4 million, representing an 89% year-over-year increase and marking a record quarterly achievement for the company. The gross margin was noted at 75.5%, reflecting a positive trend from the prior year. Furthermore, the company projected continued revenue growth for Q4 2024, with expectations set between $9.7 million and $10.5 million, alongside an effective management of expenses that led to operating income for the quarter. However, the company still faced significant net losses due to changes in the fair value of derivatives, though there was a notable improvement in Adjusted EBITDA.
Read more →SNWV▲ +74.6%on this newsshared move
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
SANUWAVE Health, Inc. will hold a conference call on November 8, 2024, to discuss its Q3 financial results. The call aims to provide stakeholders with insights into the company's performance and future outlook. SANUWAVE specializes in FDA-approved wound care products and emphasizes its commitment to research and development in medical systems. The company has acknowledged potential risks that could impact its financial projections, including supply chain issues and regulatory challenges.
Read more →SNWV▲ +74.6%on this newsshared move
Sanuwave Health Announces 1-For-375 Reverse Stock Split - Common stock will begin trading on a split-adjusted basis on
Sanuwave Health, Inc. announced a 1-for-375 reverse stock split effective October 18, 2024. This move will reduce the outstanding shares significantly, from about 1.18 billion to approximately 3.15 million. The common stock will continue to trade under the symbol SNWV and a new CUSIP number will be assigned. The reverse split will not affect the total number of authorized shares, but may lead to some stockholders receiving cash for fractional shares.
Read more →SNWV▲ +74.6%on this newsshared move
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering
SANUWAVE Health, Inc. executed a 1-for-375 reverse stock split and successfully closed a PIPE offering, raising $10.3 million at $8.25 per share. The capital restructuring aims to simplify the company's equity situation and enhance financial stability, positioning it for future growth. CEO Morgan Frank expressed hope that these measures will solidify compliance with debt covenants and allow the company to focus on profitability and expanding its wound care services. The share count is now approximately 8.5 million, following these transactions.
Read more →SNWV▲ +7.9%on this news· ran to +70% by day 3shared move
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
SANUWAVE Health, Inc. announced a 1-for-375 reverse stock split effective October 18, 2024, aimed at reducing the total number of outstanding shares. This adjustment will decrease shares from approximately 1.18 billion to about 3.15 million but will not change the total authorized shares. The split intends to enhance the company's stock price and make it more attractive to institutional investors. Stockholders will receive further information regarding the exchange process for their shares post-split.
Read more →SNWVSANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 gross margin was 73%, vs 7
Sanuwave Health, Inc. reported record quarterly revenues of $7.2 million for Q2 FY2024, marking a 53% increase from the same period in 2023. The gross margin for this quarter was 73%, slightly down from the previous year. The CEO expressed optimism about the company’s growth strategy, projecting revenue growth of 65-75% for Q3 2024. However, the company still faces challenges with high senior secured debt levels.
Read more →SNWVSANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
SANUWAVE Health, Inc. has announced it will hold a conference call on August 13, 2024, at 8:30 AM (ET) to present its Q2 financial results. The call will be accessible via telephone and an online link, with materials available on the company's investor website. SANUWAVE specializes in FDA-approved wound care products and regenerative medicine technologies. The press release also includes a caution about forward-looking statements and the risks associated with their business operations.
Read more →SNWV▲ +12.5%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2024 (Ended
SANUWAVE Health announced preliminary revenue results for Q2 2024, estimating revenues between $7.0 million and $7.2 million, marking a historic high for the company. This represents a year-over-year growth of 50% to 54% compared to the same quarter in 2023, driven primarily by a 60% increase in UltraMist revenues. The company highlights strong demand for its consumable products and intends to release full quarterly results in mid-August. Management remains focused on achieving rapid growth and establishing a leadership position in the wound care industry.
Read more →SNWV▼ -10.5%on this newsshared move
Sanuwave Announces Termination of Merger Agreement with SEP Acquisition Corp. Company to pursue alternate plans for capital structure improvement including a proposed reverse stock split and a note and warrant exchange i
Sanuwave Health, Inc. has terminated its merger agreement with SEP Acquisition Corp. in favor of pursuing alternative avenues for enhancing its capital structure. The company plans to explore options such as a reverse stock split and a note and warrant exchange. Sanuwave’s board of directors determined that exploring these alternatives is in the best interest of the company and its shareholders. CEO Morgan Frank highlighted the company’s strong position and array of potential paths for future growth.
Read more →SNWVSanuwave Provides Corporate Update Sanuwave pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to
Sanuwave Health, Inc. announced a corporate update regarding its merger with SEP Acquisition Corp. The company paid off a $6.3 million note to Celularity and has extended the merger deadline to June 30, 2024. Despite withdrawing from a Nasdaq listing due to regulatory hurdles, Sanuwave remains optimistic about uplisting to the Cboe BZX Exchange. The company projects significant revenue growth for Q2 and the fiscal year, indicating confidence in its financial outlook.
Read more →SNWVSANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE Health announced preliminary revenues for Q1 2024 ranging from $5.7 million to $5.9 million, marking the highest Q1 revenues in its history. This represents an increase of 51% to 56% compared to the same quarter in the prior year, driven largely by significant sales of its UltraMist product. CEO Morgan Frank highlighted the company’s strong performance, noting this quarter's growth surpasses previous quarters despite usual seasonal declines. Full financial results are expected to be released in mid-May 2024.
Read more →SNWV▼ -7.7%on this news
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer SANUWAVE Health, Inc.
SANUWAVE Health, Inc. has appointed Peter Sorensen as its new Chief Financial Officer. Sorensen, who has a strong background in finance and operational expertise from roles at Endogenex and LivaNova, will join SANUWAVE at a critical growth juncture. CEO Morgan Frank highlighted the importance of Sorensen's skills in enhancing the company's wound care business. Sorensen's first day at SANUWAVE will be April 1, 2024.
Read more →SNWV▼ -7.7%on this newsshared move
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended
SANUWAVE Health reported preliminary revenues of $5.7 to $5.9 million for the first quarter of 2024, the highest quarterly revenue in the company's history. This represents an increase of 51% to 56% compared to Q1 2023, primarily driven by UltraMist sales, which contributed approximately 95% of total revenues. The company noted a seasonal softness typical of the industry, yet it experienced a smaller impact than in previous years. Full quarterly results are set to be released in mid-May 2024.
Read more →SNWVSANUWAVE Announces Record Q4 and FY2023 Revenue Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 202
SANUWAVE Health, Inc. reported record financial results for Q4 and FY2023, achieving revenues of $7 million and $20.4 million, up 27% and 22% respectively from previous years. This significant growth led to an operating income of $1 million for Q4 2023, reversing a loss from the prior year. The company has also initiated guidance for FY2024, anticipating over 50% revenue growth. Additionally, SAMUWAVE is actively progressing with its merger with SEPA.
Read more →SNWVSANUWAVE Announces Record Q4 and FY2023 Revenue
SANUWAVE Health, Inc. reported record financial results for Q4 2023 and FY 2023, with revenues of $7.0 million and $20.4 million, respectively. The company achieved notable growth compared to the prior year, including positive operating income for Q4. Despite these successes, gross margins fell due to inventory write-offs, and the overall net loss for FY 2023 increased. Looking ahead, SANUWAVE is optimistic, projecting a revenue increase of over 50% for FY 2024.
Read more →SNWVSANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
SANUWAVE Health, Inc. will host a conference call on March 22, 2024, to present its Q4 and FY2023 financial results. This event will provide an update on the company's performance and discuss its next-generation FDA-approved wound care products. The company emphasizes its commitment to transparency through this call. However, potential investors are cautioned about inherent risks related to production constraints and competition.
Read more →SNWVSANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
SANUWAVE Health announced that its stockholders approved a merger with SEP Acquisition Corp. at a special meeting held on February 21, 2024. An overwhelming 99.3% of the votes cast were in favor of the business combination, indicating strong support for the strategic move. Following this approval, SANUWAVE’s management expressed optimism regarding the finalization of exchange listings and SEC filings. This merger aims to further advance SANUWAVE's portfolio of regenerative medicine products.
Read more →SNWV▼ -8.7%on this news
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
SANUWAVE Health, Inc. has announced a special meeting of stockholders scheduled for February 21, 2024, to vote on a merger with SEP Acquisition Corp. This follows a previously announced agreement to combine, expected to lead to trading under the ticker 'SNWV' on the Nasdaq. The company's board of directors has unanimously recommended that stockholders support the merger, which they believe will strengthen SANUWAVE's financial position and support its growth strategy. However, the merger is subject to various risks, including the need for regulatory approvals and stockholder votes.
Read more →SNWV▼ -11.4%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
SANUWAVE Health announced preliminary revenue results showing records for both the fourth quarter and the fiscal year 2023. The company reported Q4 revenue between $6.6 million and $6.8 million, marking a 20% to 24% increase over the same quarter in the previous year, while FY 2023 revenues are projected to be between $20.0 million and $20.2 million, reflecting a growth of 19% to 20% year-over-year. The UltraMist product line significantly contributed to this growth, accounting for almost all of the company's revenues. Future financial details will be provided in a more comprehensive report scheduled for late March 2024.
Read more →SNWV▲ +38.5%on this news· ran to +81% by day 3
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended
SANUWAVE Health has reported preliminary revenue results for the fourth quarter and fiscal year of 2023, indicating record revenues of approximately $6.6 to $6.8 million for Q4, a 20% to 24% increase compared to the same quarter in 2022. The company also projected fiscal year revenues between $20.0 million to $20.2 million, reflecting a year-over-year increase of 19% to 20%. The substantial growth was driven by strong performance in the UltraMist product line, which accounted for 95% of the company's total revenues.
Read more →SNWVSANUWAVE Announces Q3 2023 Financial Results EDEN PRAIRIE, MN, NOVEMBER 10, 2023 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products
SANUWAVE Health, Inc. reported its Q3 2023 financial results, indicating positive growth trends with increased production capabilities and anticipated revenue growth for Q4 2023. CEO Morgan Frank highlighted the elimination of manufacturing constraints and plans to expand the sales force. However, the company's net loss and significant debts raise concerns about its financial stability. Looking ahead, SANUWAVE aims to enhance production capacity significantly as it prepares for anticipated growth in 2024.
Read more →SNWV▼ -5.7%on this newsshared move
SANUWAVE Announces Q3 2023 Financial Results
SANUWAVE Health, Inc. reported its Q3 2023 financial results, showcasing a 19% increase in revenue to $5.0 million compared to Q3 2022. The company sold 55 UltraMist® systems during this quarter, reflecting improved sales and market demand. However, the net loss rose significantly to $23.7 million, primarily due to non-cash losses related to derivative liabilities. Looking ahead, SANUWAVE anticipates continued revenue growth and plans to expand production capacity, aiming for a transformational year in 2024.
Read more →SNWVSANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
SANUWAVE Health, Inc. will host a conference call on November 10, 2023, at 8:00 AM ET to discuss its Q3 2023 financial results. The company, engaged in the development of advanced wound care products, aims to maintain transparency with its investors. The call will provide insights into SANUWAVE's financial performance and future business development strategies. A replay of the call will be available until November 24, 2023.
Read more →SNWVSANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
SANUWAVE Health, Inc. announced preliminary revenue results for Q3 2023, projecting revenues between $4.7 million and $4.9 million. This represents a growth rate of 13-18% compared to Q3 2022. The significant growth in the UltraMIST product line, which accounts for more than 90% of total revenues, is highlighted. The company plans to provide a complete financial update in mid-November 2023.
Read more →SNWV▲ +17.5%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended
SANUWAVE Health has reported preliminary revenue results for Q3 2023, estimating revenues between $4.7 million and $4.9 million, indicating a growth rate of 13-18% compared to Q3 2022. The UltraMist product line, constituting over 90% of the revenue, experienced more than 25% year-on-year growth and over 10% growth against Q2 2023. The company emphasizes that these results are preliminary and may be adjusted following its financial close. A full report on quarterly performance is expected in mid-November.
Read more →SNWV▼ -25.4%on this news
Investor Presentation September 2023 This presentation ("Presentation") is for informational purposes only to assist interested parties in making an evaluation with respect to a proposed business combination and related
The investor presentation outlines the proposed business combination between SEP Acquisition Corp. and SANUWAVE Health, Inc. It serves as an informational document regarding the transaction and emphasizes the inherent risks associated with the projections presented. Stakeholders are advised to consult legal and financial advisors and to approach the financial projections with caution, given the uncertainties disclosed regarding their accuracy.
Read more →SNWV▼ -8.1%on this news
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasda
SANUWAVE Health, Inc. has entered into a merger agreement with SEP Acquisition Corp., a special purpose acquisition company. The transaction will create a publicly listed entity focused on improving wound healing through next-generation care products, with an enterprise value of $127.5 million. SANUWAVE shareholders are expected to retain approximately 69.6% equity in the new company. The merger is anticipated to strengthen SANUWAVE's market presence and streamline its operations as the company aims for profitable growth in the wound care market.
Read more →SNWV▼ -7.1%on this news· ran to -21% by day 3
SANUWAVE Announces Q2 2023 Financial Results EDEN PRAIRIE, MN, AUGUST 11, 2023 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products,
SANUWAVE Health, Inc. reported its financial results for Q2 2023, highlighting significant revenue growth despite ongoing capacity constraints. The company aims to improve inventory supply and is projecting a revenue growth of 15% to 25% year-over-year for Q3 2023. CEO Morgan Frank emphasized ongoing efforts in cost-cutting, process optimization, and achieving operating profitability. However, the company continues to face financial challenges, including a significant operating loss due to prior debts.
Read more →SNWV▼ -7.1%on this news· ran to -21% by day 3
SANUWAVE Announces Q2 2023 Financial Results
SANUWAVE Health, Inc. reported its Q2 2023 financial results, showcasing a 20% revenue increase to $4.7 million. Despite improvement in several areas, including gross margin and the appointment of new leadership, the company experienced a net loss of $7.3 million, largely attributed to non-cash losses. Supply chain constraints continue to challenge the organization, though optimistic revenue growth expectations for Q3 were communicated alongside announcements of various strategic partnerships and initiatives.
Read more →SNWVSANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
SANUWAVE Health, Inc. is set to host a live conference call on August 11, 2023, to discuss its financial results for Q2 2023. The call demonstrates the company's commitment to transparency with its stakeholders. SANUWAVE specializes in innovative, FDA-approved wound care products, focusing on developing and commercializing medical systems for tissue repair. The company has outlined potential risks associated with future performance and the regulatory landscape that may affect its operations.
Read more →SNWV▲ +12.4%on this news
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
SANUWAVE Health, Inc. has entered into a long-term distribution agreement with Pacific Medical, Inc. to promote its UltraMIST line of wound care products throughout the Western United States. This partnership will leverage Pacific Medical's experienced sales team, comprising over 215 representatives, to enhance the market presence of SANUWAVE's 'Energy First' treatment modalities. The agreement is aimed at establishing SANUWAVE as a leader in advanced wound care solutions. The collaboration is seen as a strategic move to bolster sales and innovation in the medical field.
Read more →SNWVSANUWAVE Health Appoints Industry Veteran Andrew Walko as President SANUWAVE Health, Inc.
SANUWAVE Health has appointed Andrew Walko as its new President, effective July 31, 2023. Walko has 17 years of experience in manufacturing, production, and logistics, previously serving as President of Biomerics. The company is optimistic about Walko's capabilities to enhance its manufacturing and leadership in the wound care market. SANUWAVE focuses on developing advanced medical solutions for healing and regeneration.
Read more →SNWV▲ +10.6%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
SANUWAVE Health, Inc. announced preliminary revenues for the second quarter of 2023, expected to be in the range of $4.5 to $4.7 million, indicating a growth of 16-21% compared to Q2 2022. This outcome aligns with earlier guidance issued in the Q1 earnings release. CEO Morgan Frank expressed optimism regarding accelerating growth in subsequent quarters, despite facing production constraints. The company plans to publish its complete quarterly results in mid-August and continues to focus on developing its next-generation wound care products.
Read more →SNWV▲ +13.5%on this news
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended
SANUWAVE Health, Inc. reported preliminary revenues of $4.5 to $4.7 million for the second quarter of 2023, reflecting a growth rate of 16-21% over the same period last year. These results align with previously provided guidance from their Q1 2023 earnings release. CEO Morgan Frank expressed optimism about accelerating growth despite ongoing production constraints. The final revenue figures will be disclosed in mid-August, pending completion of the quarter-end financial closing process.
Read more →SNWV▼ -15%on this news
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer Published
SANUWAVE Health, Inc. has appointed Morgan Frank as the new Chief Executive Officer, leveraging his extensive 29 years of experience in life sciences and technology. Kevin Richardson will continue to play a key role as Chief Strategic Officer after transitioning from the CEO position. Frank aims to rapidly expand SANUWAVE's capabilities and commercial options during this exciting growth phase for the company, which specializes in FDA-approved wound care products.
Read more →SNWV▼ -20%on this news
Sanuwave announces Q1 2023 financial results SANUWAVE Health, Inc.
SANUWAVE Health, Inc. announced its financial results for Q1 2023, highlighting positive customer interest at various conferences. Despite supply constraints impacting inventory, the company forecasts revenue growth of 15% to 25% for Q2 2023. During the first quarter, SANUWAVE experienced a significant net loss of $13,080,000, which indicates ongoing financial challenges alongside its commitment to improve patient care through innovative technologies.
Read more →SNWV▼ -20%on this news
SANUWAVE Announces Q1 2023 Financial Results
SANUWAVE Health, Inc. reported its Q1 2023 financial results, highlighting an 18% revenue increase to $3.8 million. The sales of UltraMist® systems and applicator cases also showed positive growth. However, the company experienced a decrease in gross margin percentage and incurred a consistent operating loss of $2.0 million. Looking forward, SANUWAVE anticipates a revenue growth of 15-25% in Q2 2023, although challenges remain due to inventory constraints.
Read more →SNWV▲ +28.5%on this newsshared move
SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update
SANUWAVE Health, Inc. will hold a live conference call on May 12, 2023, to discuss financial updates and recent strategic initiatives. The company specializes in wound care products and regenerative medicine, highlighting its focus on innovative technologies for healing. Participants can access the call via provided dial-in numbers or the Call me™ link. A replay of the conference will be available until May 26, 2023.
Read more →SNWV▼ -10.4%on this news
SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference
SANUWAVE Health, Inc. will participate in the 2023 Symposium on Advanced Wound Care Spring conference, co-located with the Diabetic Limb Salvage conference, from April 26-30, 2023, in National Harbor, MD. The event is designed for leading experts in wound care to gather, share knowledge, and discuss advancements in the field. SANUWAVE will present six posters focusing on its innovative non-invasive regenerative medicine solutions aimed at treating chronic wounds, aiming to advance the science and patient care.
Read more →SNWVSANUWAVE Attends 3rd Annual Leaders in Wound Healing Conference
SANUWAVE attended the 3rd Annual Leaders in Wound Healing Conference in New Orleans, an exclusive event for leaders in wound healing. The company expressed its honor in participating and contributing to discussions on innovative healing technologies. SANUWAVE showcased its commitment to regenerative medicine, particularly its solutions for chronic wound healing. Key presentations at the conference emphasized the benefits of their UltraMIST therapy, highlighting SANUWAVE's role in improving patient outcomes.
Read more →SNWVSANUWAVE Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
SANUWAVE Health, Inc. reported strong financial results for Q4 and full year 2022, highlighting record revenues and improving gross margins. However, the company has faced supply chain constraints that affected operations in early 2023. In addition, significant changes to the leadership team were announced, aimed at enhancing sales and operational efficiency. Despite past financial misstatements, SANUWAVE is optimistic about revenue growth in the upcoming quarters as supply issues are alleviated.
Read more →SNWV▲ +22.6%on this newsshared move
SANUWAVE Will Host a Live Conference Call and Webcast April 3, 2023 at 9:00 AM to Provide a Financial and Business Update
SANUWAVE Health, Inc. will hold a live conference call on April 3, 2023, at 9:00 AM (EDT) to provide a financial update and discuss recent strategic initiatives. The company specializes in next-generation wound care products and aims to improve healing processes through its patented medical systems. Investors can access the call via telephone or through a dedicated link. A replay will be available until April 17, 2023.
Read more →SNWVSANUWAVE Health Commences Trading on the OTCQB Under Ticker Symbol SNWV
SANUWAVE Health, Inc. has begun trading on the OTCQB under the ticker symbol SNWV, highlighting a vital growth step for the company. It specializes in the development and commercialization of FDA-approved wound care products, emphasizing non-invasive technologies for healing and tissue regeneration. However, the company also faces notable risks related to regulatory approval and market competition, as indicated in its forward-looking statements. Investors are urged to consider these factors when assessing the company’s potential.
Read more →SNWV▼ -20%on this news
SANUWAVE Announces Q3 Earnings
EDEN PRAIRIE, MN, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 3rd quarter results. For the three-months and nine-months ended September 30, 2022:
Read more →SNWV▼ -20%on this news
Kevin Richardson, II Chief Executive Officer Investors@Sanuwave.com SANUWAVE Announces Q3 earnings
Kevin Richardson, II Chief Executive Officer Investors@Sanuwave.com SANUWAVE Announces Q3 earnings EDEN PRARIE, MN, November 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation FDA-approved wound care pro
Read more →SNWVInvestor Presentation October, 2022 Forward Looking Statements This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the Compan
Investor Presentation October, 2022 Forward Looking Statements This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the Company's current views with respect to certain current and futu
Read more →SNWV▼ -16.4%on this newsshared move
SANUWAVE’s Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)
EDEN PRAIRIE, MN, Oct. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is excited to announce that three abstracts highlighting the role of the company’s dermaPACE system in clinical c
Read more →SNWV▼ -6.7%on this news
SANUWAVE Announces Chief Financial Officer
SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment
Read more →SNWVSANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update
Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 202
Read more →SNWV▼ -7.1%on this news
SANUWAVE Appoints New Board Chairman
SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is pleased to announce the appointment of Mr. Morgan C. Frank as new Board Chairman effective today, August 5, 2022.
Read more →SNWV▼ -7.1%on this news
SANUWAVE Closes $12 Million Capital Raise
SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the closing of its $12 million private placement. Use of proceeds is to expand production
Read more →SNWV▼ -7.1%on this news
Sabrina Ruelle Senior Director, Marketing & Program Management Sabrina.Ruelle@Sanuwave.com SANUWAVE Closes $12 Million Capital Raise SUWANEE, GA
Senior Director, Marketing & Program Management Sabrina.Ruelle@Sanuwave.com SANUWAVE Closes $12 Million Capital Raise SUWANEE, GA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation FDA-approved woun
Read more →SNWVSANUWAVE Treats Football Legend Jim McMahon With ENERGY FIRST
SUWANEE, GA, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a Medical Device Company Specializing in Chronic Wound Care, Helps Treat Football Legend Jim McMahon with their ENERGY FIRST devices dermaPACE® and UltraMIST®. Jim McMahon Jr.
Read more →SNWVSANUWAVE Business Update – June 2022
Estimated June Revenue Increase of 75% Year Over Year Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month SUWANEE, GA, July 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- On July 14, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of ne
Read more →SNWV▲ +11.8%on this news
SANUWAVE Business Update
Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over Month SUWANEE, GA, June 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- On June 7, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next
Read more →SNWV▼ -16.7%on this news· ran to -83% by day 3
SANUWAVE Health Announces Patent Activity from March 2021 to March 2022
SANUWAVE announces patents issued over the past year SUWANEE, GA, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV) focuses on the development and commercialization of innovative advanced wound care medical systems for the repair and regenerati
Read more →SNWVSANUWAVE Announces New Board Leadership SANUWAVE announces addition of three new board members this quarter SUWANEE, GA - (NewMediaWire)
SANUWAVE Announces New Board Leadership SANUWAVE announces addition of three new board members this quarter SUWANEE, GA - (NewMediaWire) - April 12, 2022 - SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, today announced three new board
Read more →SNWVSANUWAVE Announces New Board Leadership
SANUWAVE announces addition of three new board members this quarter SUWANEE, GA, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, today announced three new board members will join as one
Read more →SNWV▼ -5.6%on this news· ran to -17% by day 1
SANUWAVE Health to Present at the Emerging Growth Conference on March 2, 2022
SANUWAVE invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference SUWANEE, GA, March 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (SNWV), a leadin
Read more →SNWV▲ +5.9%on this newsshared move
SANUWAVE Health to Host Conference Call and Provide Business Update
SANUWAVE will hold a conference call on Wednesday, March 2, 2022 at 9:00 am ET SUWANEE, GA, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, announced it will hold a conference call on
Read more →SNWVSANUWAVE Health Provides Business Update
SUWANEE, GA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (PINK: SNWV), a leading provider of next-generation wound care products, has announced that as of September 28, 2021, the Company’s shares will no longer be traded on the OTC Market Pink, or
Read more →SNWVSANUWAVE Announces Collaboration with NASA for the Mitigation of Bacterial Biofilms Formed in the Water Processor Assembly used on International Space Station (ISS) and for Future Moon Base and Mars Colony
SUWANEE, GA, July 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), announces collaboration with National Aeronautics and Space Administration (NASA). One of the most important objectives of this decade for National Aeronautics and Space Admin
Read more →SNWVSANUWAVE Health Announces $3 Million Financing - Capital to Accelerate the Company's Near-Term Growth Initiatives - SUWANEE, GA
SANUWAVE Health Announces $3 Million Financing - Capital to Accelerate the Company's Near-Term Growth Initiatives - SUWANEE, GA, April 28, 2021 -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, today announced a $3 million priva
Read more →SNWVSANUWAVE Health to Present Energy First Solutions at Upcoming Wound Care Industry Conferences
SUWANEE, GA, April 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, announced today that the Company will be participating in a number of leading wound care industry conferences – both
Read more →SNWVSANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership
Agreement Incorporates SANUWAVE’s Entire Wound Care Product Portfolio SUWANEE, GA, March 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product
Read more →SNWVSANUWAVE Health Announces Exclusive Distribution Agreement for Southeast Asia with Leading Taiwanese Medical Device Distributor Kingdom Brother
Partnership Further Extends the Availability of SANUWAVE’s Energy-Based Medical Systems to a Region with the Second Highest Prevalence of Diabetes in the World SUWANEE, GA, March 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the
Read more →SNWVSANUWAVE Health Secures Customer Medical Device Financing
A CIT Facility Helps Expand the Market for SANUWAVE’s Products SUWANEE, GA, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfol
Read more →SNWVSANUWAVE Health Announces Distribution Agreement with Labb Solutions
SANUWAVE to Distribute dermaPACE® System and UltraMIST® System in Turkey and in Select Eastern Europe and Middle East Countries SUWANEE, GA, March 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercializati
Read more →SNWVSANUWAVE Health Announces Physician Office Channel Partnership with DocShop Pro
Enters into a Reseller Agreement with a Leading Healthcare Supply Chain Solutions Marketplace Company to Market and Sell SANUWAVE’s Wound Care Products SUWANEE, GA, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the develop
Read more →SNWVSANUWAVE Health Reports Increased Reimbursement Payments for UltraMist and dermaPACE in 2021
Underscores continued medical need for and clinical utility of SANUWAVE Health's energy transfer therapeutics in advanced wound care SUWANEE, GA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commerciali
Read more →SNWVSANUWAVE Health to Participate in LD Micro Main Event XIII
Highlights Significant Growth in Wound Care Franchise at Premier Small Cap Investor Conference Fourth Quarter 2020 Product Revenue to Grow 50% Sequentially; Fiscal 2021 Revenue to Increase More Than 300% SUWANEE, GA, Dec. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAV
Read more →SNWVSANUWAVE Health Reports Third Quarter 2020 Financial Results
Transformational Acquisition Positions for Significant Growth in Fourth Quarter 2020 and Beyond SUWANEE, GA, Nov. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative adv
Read more →SNWVSANUWAVE Health Significantly Strengthens Intellectual Property Portfolio with Multiple Important Patent Grants for Its Shockwave Technology
US and International Patents Fortify dermaPACE Patent Position in Wound Care and Highlight its Innovation SUWANEE, GA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and inno
Read more →SNWVSANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)
Forms Joint Venture with MEDSTENT, S.A. to Market dermaPACE in Mexico to Treat a Variety of Chronic Wounds SUWANEE, GA, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and inn
Read more →SNWVSANUWAVE Health to Participate in Multiple U.S. Wound Care Medical Meetings in October
Highlighting the clinical advantages of the Company’s ‘Energy First’ approach to healing chronic wounds with dermaPACE® and UltraMIST® Systems SUWANEE, GA, Sept. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and
Read more →SNWVSANUWAVE Health Hosts Symposium on dermaPACE at Wounds Canada Virtual Conference
World Renowned Wound Care Experts to Lead Discussion on Role of dermaPACE in the Treatment of Chronic Wounds SUWANEE, GA, Sept. 22, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robust
Read more →SNWVSANUWAVE Health Announces Reimbursement Coverage for BIOVANCE from Largest Medicare and Medicaid Administrator in U.S.
24.5 Million Covered Lives Now Eligible for Biologic Advanced Wound Care Treatment through Centene Corporation SUWANEE, GA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development and commercialization of a robus
Read more →SNWVSANUWAVE Health to Participate in Upcoming September Investor Conferences
Management to Highlight Significant Opportunities with Recent Acquisition of Celularity’s UltraMIST Assets and Preview Plans for Balance of 2020 SUWANEE, GA, Aug. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focus is the development
Read more →SNWVSANUWAVE Health Receives Approval from The National Health Surveillance Agency (ANVISA) to Market dermaPACE to Treat Chronic Wounds in Brazil
Plans for Immediate Commercial Launch via Established Joint Venture SUWANEE, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of patented PACE® technology platform for the repair and r
Read more →SNWVSANUWAVE TO PROVIDE UPDATE ON RECENTLY ACQUIRED WOUND CARE
SANUWAVE TO PROVIDE UPDATE ON RECENTLY ACQUIRED WOUND CARE SUWANEE, GA, August 11, 2020 SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Wednesday, August 12, 2020, beginning at 1PM Eastern Time to provide an update on the re
Read more →SNWVSANUWAVE HEALTH COMPLETES ACQUISITION OF
SANUWAVE HEALTH COMPLETES ACQUISITION OF THE WOUND CARE ASSETS OF CELULARITY CONFERENCE CALL SCHEDULED FOR WEDNESDAY 1 P.M. EDT SUWANEE, GA, August 10, 2020 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has completed the acquisition of the wound care assets o
Read more →SNWVSANUWAVE to Provide Update on Recently Acquired Wound Care Assets
SUWANEE, GA, Aug. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Wednesday, August 12, 2020, beginning at 1PM Eastern Time to provide an update on the recently acquired wound car
Read more →SNWVSANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity
Conference Call Scheduled for Wednesday 1:00 p.m. EDT SUWANEE, GA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has completed the acquisition of the wound care assets of Celularity, consisting of the UltraMIST®
Read more →SNWVSANUWAVE Health, Inc. Announces Successful Results of Annual Meeting of Stockholders
SUWANEE, GA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE” or the “Company”) today announced the results from the Company’s 2020 Annual Meeting of Stockholders, held Thursday, July 23, 2020. All director nominees, including
Read more →SNWVSANUWAVE to Present at June 2020 Lytham Partners Virtual Investor Growth Conference
SUWANEE, Ga., June 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is scheduled to participate in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 3:00p
Read more →SNWVSANUWAVE HEALTH ENTERS INTO EXCLUSIVE LETTER OF INTENT TO ACQUIRE CELULARITY'S ULTRAMIST® AND EXCLUSIVE PARTNERSHIP RIGHTS FOR WOUND CARE BIOLOGIC PRODUCTS Contemplated Transaction Would Create a Leading Provider of
SANUWAVE HEALTH ENTERS INTO EXCLUSIVE LETTER OF INTENT TO ACQUIRE CELULARITY'S ULTRAMIST AND EXCLUSIVE PARTNERSHIP RIGHTS FOR WOUND CARE BIOLOGIC PRODUCTS Contemplated Transaction Would Create a Leading Provider of Advanced Wound Care Solutions that Improve Clinical Outcomes
Read more →SNWVSANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020
SUWANEE, GA, June 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a live webcast and conference call on Wednesday, June 10, 2020, beginning at 9AM Eastern Time to provide a business update. Sharehold
Read more →SNWVSECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 28, SANUWAVE Health, Inc. (Exact Name of Registrant as Specified in Nevada 000-52985 20-11
Read more →SNWVSANUWAVE HEALTH, INC. CONFERENCE CALL TO DISCUSS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE MONDAY, MAY 18, 2020 10:00 a.m. Eastern Time Operator Good day, ladies and gentlemen, and welcome to you
SANUWAVE HEALTH, INC. CONFERENCE CALL TO DISCUSS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE MONDAY, MAY 18, 2020 10:00 a.m. Eastern Time day, ladies and gentlemen, and welcome to your SANUWAVE First Quarter 2020 Earnings Call. [Operator Instructions]
Read more →SNWVSANUWAVE Health Reports First Quarter 2020 Financial Results
SUWANEE, GA, May 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the quarter ended March 31, 2020 with the SEC on Friday, May 15, 2020. The Company will also host a conference call today, May 18, 2020, at 10:00 a.
Read more →SNWVSANUWAVE HEALTH REPORTS FIRST QUARTER 2020
SANUWAVE HEALTH REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS SUWANEE, GA, May 18, 2020 - SANUWAVE Health, Inc. (OTCQB:SNWV) reported financial results for the quarter ended March 31, 2020 with the SEC on Friday, May 15, 2020. The Company will also host a conference call toda
Read more →SNWVSANUWAVE HEALTH PARTNERS WITH THE MOBILE HEALTH COMPANY, A
SANUWAVE HEALTH PARTNERS WITH THE MOBILE HEALTH COMPANY, A NEW COMPANY FORMED BY FORMER PRESIDENT SHRI PARIKH SUWANEE, GA, May 18, 2020 - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce they will be offering System solutions to treat patients in a home setting. S
Read more →SNWVSANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020
SUWANEE, GA, May 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Monday, May 18, 2020, beginning at 10AM Eastern Time to discuss the first quarter of 2020 financial results, provi
Read more →SNWVSANUWAVE Health to Deliver dermaPACE to Patients in the Home Setting
SUWANEE, GA, May 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce they will be offering dermaPACE® System solutions to treat patients in a home setting. SANUWAVE Health has quickly adapted to the changes occurring in the
Read more →SNWVSANUWAVE Health Announces Successful Filing of Patent for Use of Shockwaves to Treat Respiratory Ailments, Including Viral Infections Such as COVID-19
Concept Submitted to National Science Foundation for Funding Grant SUWANEE, GA, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today the successful filing of a patent for use of shockwaves to treat respiratory ailments includ
Read more →SNWVSANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
SUWANEE, GA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronix’s surface acoustic wave ultrasound technology in the wound care market. Under t
Read more →SNWVSANUWAVE Health Reports Full Year 2019 Financial Results
COVID-19 Related Business Update SUWANEE, GA, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the year ended December 31, 2019 with the SEC on Monday, March 30, 2020. The Company will also host a conferenc
Read more →SNWVSANUWAVE HEALTH, INC. CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FULL FISCAL YEAR 2019 FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE TUESDAY, MARCH 31, 2020 9:00 a.m. Eastern Time Operator Ladies and gentlemen good
SANUWAVE HEALTH, INC. CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FULL FISCAL YEAR FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE TUESDAY, MARCH 31, 2020 9:00 a.m. Eastern Time and gentlemen good day, and thank you all for joining this SANUWAVE 2019 Annual Earnings Confe
Read more →SNWVSANUWAVE Health to Hold 2019 Annual Financial Results and Business Update Call on Tuesday, March 31, 2020
SUWANEE, GA, March 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Tuesday, March 31, 2020, beginning at 9AM Eastern Time to discuss the 2019 financial results, provide a business
Read more →SNWVSANUWAVE Participating at World Union of Wound Healing Society (WUWHS) 2020 in Abu Dhabi, UAE. Booth #HS62&63
SUWANEE, GA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) – is pleased and proud to announce their participation and world-wide launch of dermaPACE® at the World Union of Wound Healing Society (WUWHS) 2020 in Abu Dhabi, UAE March 8 to
Read more →SNWVSANUWAVE
SANUWAVE HEALTH APPOINTS DR. TOM PRICE TO ITS BOARD OF SUWANEE, GA, February 7, 2020 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE.
Read more →SNWVSANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors
SUWANEE, GA, Feb. 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s extensive
Read more →SNWVSANUWAVE Completes Offering, Funding Allows Path to Profitability in 2020
SUWANEE, GA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce the completion of our follow on equity offering. The combined offerings have brought over $5 million of investment capital to the company between the Decem
Read more →SNWVSANUWAVE Appoints DIVICOMED SRL as Exclusive Distributor for dermaPACE System in Bolivia
SUWANEE, GA, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has appointed DIVICOMED SRL as the exclusive distributor for the dermaPACE® System in Bolivia. DIVICOMED SRL is a leading medical equipment and a
Read more →SNWVMANAGEMENT PRESENTATION Untitled Document
MANAGEMENT PRESENTATION Untitled Document
Read more →SNWVSANUWAVE Health Reports Third Quarter 2019 Financial Results
SUWANEE, Ga., Nov. 15, 2019 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2019 with the SEC on Thursday, November 14, 2019. The Company will also host a conference call today, November 15, 2019
Read more →SNWVSANUWAVE HEALTH REPORTS THIRD QUARTER 2019
SANUWAVE HEALTH REPORTS THIRD QUARTER 2019 FINANCIAL EXPECTS FOURTH QUARTER REVENUE TO EXCEED ONE MILLION SUWANEE, GA, November 15, 2019 - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2019 with the SEC on Thu
Read more →SNWVSANUWAVE Signs Distribution Partnership With Ametus Group, Setting Stage for Rapid Expansion in 2020
Re-Affirms Guidance of 110 dermaPACE® Placements in 2019 SUWANEE, GA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has signed a distribution partnership agreement with Ametus Group for the commercializat
Read more →SNWVSANUWAVE Health to Hold Third Quarter 2019 Financial Results and Business Update Call on Friday, November 15, 2019
SUWANEE, GA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2019 this week. The Company will also host a conference call on Friday
Read more →SNWVSANUWAVE Signs Agreement for dermaPACE System Joint Venture in Brazil
Company Receives Cash Payments for Territorial Rights SUWANEE, GA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has signed a term sheet for a Brazilian joint venture for the dermaPACE® System with IDIC G
Read more →SNWVSANUWAVE Successfully Completes Extensive Round of Quality System and Technical File Audits
SUWANEE, GA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating shockwave systems for the re
Read more →SNWVSANUWAVE Launches Partnership in Oman
SPONSORSHIP & ATTENDANCE AT GDFC MUSCAT OMAN NOV 7-10 INITIAL ORDERS UNDERWAY SUWANEE, GA, Oct. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of nonin
Read more →SNWVSANUWAVE Continues to Increase Clinical Symposia Presence With SAWC Fall 2019
Symposia and Posters Presenting Compelling Clinical Evidence in Treating Diabetic Foot Ulcers With dermaPACE®System SUWANEE, GA, Oct. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to provide an update of current clinical events a
Read more →SNWVSANUWAVE Increases Clinical Symposia Presence With Three Posters at Wounds Canada
Studies Show Significant Improvements When dermaPACE® System Was Used in the Treatment of Chronic Wounds SUWANEE, GA, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to provide an update of current clinical events and news inv
Read more →SNWVSANUWAVE to Attend a Total of Eight Medical Conferences in the Fourth Quarter of 2019 Supported by Symposiums, Posters, and KOLs
SUWANEE, GA, Sept. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is exc
Read more →SNWVSANUWAVE HEALTH REPORTS SECOND QUARTER 2019
SANUWAVE HEALTH REPORTS SECOND QUARTER 2019 FINANCIAL SUWANEE, GA, August 15, 2019 - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended June 30, 2019 with the SEC on Wednesday, August 14, 2019. The Company will also host a conference ca
Read more →SNWVSANUWAVE Health Reports Second Quarter 2019 Financial Results
SUWANEE, Ga., Aug. 15, 2019 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended June 30, 2019 with the SEC on Wednesday, August 14, 2019. The Company will also host a conference call today, August 15, 2019, 2019 at 9:00 a.
Read more →SNWVSANUWAVE Accelerates Claims Coverage Expansion One Year Ahead of Expectations Due to Recent Positive Change in Reimbursement Coverage
SUWANEE, GA, Aug. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today an
Read more →SNWVSANUWAVE to Hold Second Quarter 2019 Financial Results and Business Update Call on Thursday, August 15, 2019
SUWANEE, GA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the second quarter ended June 30, 2019 this week. The Company will also host a conference call on Thursday,
Read more →SNWVSANUWAVE Announces New Issue of “The Pulse” Newsletter, Summer 2019
WE ARE HIRING IN NEW REGIONS SUWANEE, GA, Aug. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in
Read more →SNWVSANUWAVE Increases Clinical Symposia Presence With Recent Abstracts and Posters: Clinical Results Using the dermaPACE System in the Treatment of Chronic Wounds and orthoPACE System in Basic Orthopedic Research
SUWANEE, GA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to provide an update of current clinical events and news involving the company’s dermaPACE System, the only shockwave product cleared by FDA for the treatment of Diab
Read more →SNWVSANUWAVE Exhibiting at the APMA 2019 Annual Scientific Meeting in Salt Lake City, Utah July 11-14, 2019
-- Poster Presentation and a Wound Care Workshop hosted by Dr. Windy Cole Friday July 12 1:30-3:30 -- Visit us at Booth Number 520 SUWANEE, GA, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will
Read more →SNWVSANUWAVE President, Shri Parikh, Receives Top 100 Healthcare Leaders Award
Suwanee, GA, June 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is prou
Read more →SNWVSANUWAVE Announces Second Peer Review Article Published on Treatment of Diabetic Foot Ulcers
Strong efficacy and safety results supported throughout article Supports acceleration of placements and insurance coverage during 2019 roll out Published in Journal of Wound Care: June 2019 Suwanee, GA, June 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SANUWAVE Health, Inc.
Read more →SNWVSANUWAVE Raises Guidance For Full Year To 110 Device Placements
SUWANEE, Ga., May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended March 31, 2019 with the SEC on Monday, May 20, 2019. The Company will also host a conference call today, May 21, 2019 at 9
Read more →SNWVSanuwave Health Reports First Quarter 2019 Financial Results
SUWANEE, Ga., May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended March 31, 2019 with the SEC on Monday, May 20, 2019. The Company will also host a conference call today, May 21, 2019 at 9
Read more →SNWVSANUWAVE Health Engages Alira Health to Explore Strategic Alternatives and Partnerships in the European Wound Market
Suwanee, GA, May 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today a
Read more →SNWVSANUWAVE Health to Hold First Quarter 2019 Financial Results and Business Update Call on Tuesday, May 21, 2019
SUWANEE, GA, May 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2019 next week. The Company will also host a conference call on Tuesday, Ma
Read more →SNWVSANUWAVE Health Comments on Recent News and Investor Relations Promotional Activity
Suwanee, GA, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB:SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today c
Read more →SNWVSANUWAVE Health Enters the Carolinas, Hires Key Representative and Will Participate in the Modern Wound Care Management Conference April 26-27 in Greensboro, NC
Suwanee, GA, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) ( www.sanuwave.com) announced they have entered North and South Carolina as their 5th and 6th markets in 2019, also hiring David Cummings to lead SANUWAVE in the Carolinas. SA
Read more →SNWVSANUWAVE Provides an Update on International Registrations Received, Attendance at Trade Shows and ISO Certification
SUWANEE, GA, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) is pleased to provide an update regarding the Company’s regulatory status in the worldwide sales and distribution of the company’s medical devices. In addition to our long-sta
Read more →SNWVSANUWAVE Launches Two Studies: Perfusion and Dosing; Results Expected in 2019
Suwanee, GA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCBB: SNWV) (www.sanuwave.com): SANUWAVE® is pleased to announce initial enrollment beginning this week in two company-sponsored studies. First, SANUWAVE is sponsoring an initial case ser
Read more →SNWVSANUWAVE Receives U.S. and European Patents for Intracorporeal Shockwave Systems for Treating Blood Vessels in Cardiology and Endovascular Fields
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, receiv
Read more →SNWVSANUWAVE Health Reports Record 2018 Financial Results
SUWANEE, Ga., March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) will report financial results for the year ended December 31, 2018 with the SEC on Monday, April 1, 2019. The Company will also host a conference call today, March 29, 2019 a
Read more →SNWVSANUWAVE HEALTH REPORTS RECORD 2018 FINANCIAL RESULTS FULL YEAR REVENUE INCREASED OVER 150% SUWANEE, GA
SANUWAVE HEALTH REPORTS RECORD 2018 FINANCIAL RESULTS FULL YEAR REVENUE INCREASED OVER 150% SUWANEE, GA, March 29, 2019 SANUWAVE Health, Inc. (OTCQB: SNWV) will report financial results for the year ended December 31, 2018 with the SEC on Monday, April 1, 2019. The Company w
Read more →SNWVSANUWAVE Health to Hold 2018 Financial Results and Business Update Call on Friday, March 29, 2019
SUWANEE, GA, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Friday, March 29, 2019, beginning at 10AM Eastern Time to discuss the 2018 financial results, provide a business
Read more →SNWVSANUWAVE Health, Inc. Announces New Issue of The Pulse, Spring 2019
SUWANEE, GA, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, announc
Read more →SNWVSANUWAVE Announces Plans to Attend a Total of Seven Medical and Investor Conferences in March, April and May
SUWANEE, GA, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is exc
Read more →SNWVSANUWAVE, Proud Winner of the JWC 2019 Innovation in Chronic Wound Healing Award for dermaPACE
SUWANEE, GA, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is exc
Read more →SNWVSANUWAVE'S Letter to Stakeholders
A Look Back at 2018, a Glance Forward to 2019 and Beyond SUWANEE, GA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – SANUWAVE Health, Inc. (OTCQB: SNWV) Dear SANUWAVE stakeholders, This past year marked a turning point for SANUWAVE. We achieved several milestones includi
Read more →SNWVSANUWAVE Health, Inc. Announces a New Shock This Blog Regarding an Interview With Michael Stolarski, the Owner, President, and CEO of Premier Shockwave, Inc. and Premier Shockwave Wound Care, Inc.
SUWANEE, GA, Dec. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, announce
Read more →SNWVSANUWAVE Health, Inc. Announces a New SHOCK THIS Blog: Interview With Shri Parikh, President of the Healthcare Division
SUWANEE, GA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, announce
Read more →SNWVSANUWAVE Celebrates Prolific Success From Increased Patent Activity This Year
SUWANEE, GA, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, reflects
Read more →SNWVSANUWAVE Announces Attendance at the 5th Annual Innovations In Wound Healing Symposium, Key West, December 6-9, 2018
SUWANEE, GA, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) SANUWAVE is excited to announce attendance at the 5th annual Innovations In Wound Healing Symposium in Key West, Florida on December 6-9. The symposium topics are based on inno
Read more →SNWVSANUWAVE Announces Peer Review Article Published in Journal of Wound Care (Dec. 2018): Extracorporeal Shock Wave Technology (ESWT) as Compared to Standard of Care in DFUs
SUWANEE, GA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, announce
Read more →SNWVSANUWAVE HEALTH REPORTS RECORD THIRD QUARTER REVENUE Total Revenue Increase of 269%; Initial US treatments have begun, New President, Shri Parikh, to Discuss on Conference Call at 10 am SUWANEE, GA
SANUWAVE HEALTH REPORTS RECORD THIRD QUARTER REVENUE Total Revenue Increase of 269%; Initial US treatments have begun, New President, Shri Parikh, to Discuss on Conference Call at 10 am SUWANEE, GA, November 20, 2018 SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial res
Read more →SNWVSANUWAVE Health Reports Record Third Quarter Revenue
Total Revenue Increase of 269%; Initial US treatments have begun, New President, Shri Parikh, to Discuss on Conference Call at 10 am SUWANEE, Ga., Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three
Read more →SNWVSANUWAVE HEALTH REPORTS STRONG THIRD QUARTER REVENUE Product Revenue Increase of 99% for 9 months Initial US Treatments Have Begun SUWANEE, GA
SANUWAVE HEALTH REPORTS STRONG THIRD QUARTER REVENUE Product Revenue Increase of 99% for 9 months Initial US Treatments Have Begun SUWANEE, GA, November 15, 2018 SANUWAVE Health, Inc. report financial results for the three months ended September 30, 2018 with the SEC in the
Read more →SNWVSANUWAVE Health to Hold Third Quarter 2018 Financial Results and Business Update Call on Thursday, November 15, 2018
SUWANEE, GA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2018 this week. The Company will also host a conference call on Thursd
Read more →SNWVSANUWAVE Announces Exhibition at Fall SAWC 2018 Including a Poster and Three Presentations - Visit us at Booth #441
SUWANEE, GA , Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at SAWC (Symposium on Advanced Wound Care) in Las Vegas, NV on November 2 - 4, 2018. This is SANUWAVE’s next opportunity to
Read more →SNWVSANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to Report on a 300% Increase in Revenue
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- (OTCQB:SNWV) -- SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to report on a 300% increase in revenue. The interview began with Jolly noting, “You know, you guys knocked it
Read more →SNWVSANUWAVE HEALTH REPORTS RECORD SECOND QUARTER REVENUE INCREASE AND SIGNIFICANT MILESTONES ACHIEVED DURING THE QUARTER Company expects continued growth in 2nd half of 2018 from product sales in US an
SANUWAVE HEALTH REPORTS RECORD SECOND QUARTER REVENUE INCREASE AND SIGNIFICANT MILESTONES ACHIEVED DURING THE QUARTER Company expects continued growth in 2nd half of 2018 from product sales in US and International markets SUWANEE, GA, August 14, 2018 SANUWAVE Health, Inc. (OT
Read more →SNWVSANUWAVE Health Reports Record Second Quarter Revenue Increase and Significant Milestones Achieved During the Quarter
SUWANEE, Ga., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended June 30, 2018 with the SEC on Tuesday, August 14, 2018 and will provide a business update on a conference call today, August 14, 2018 at 10:00
Read more →SNWVSANUWAVE Health to Hold Second Quarter 2018 Financial Results and Business Update Call on Tuesday, August 14, 2018
SUWANEE, GA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the second quarter ended June 30, 2018, on August 13, 2018. The Company will also host a conference call on Tuesday, August 14,
Read more →SNWVSANUWAVE Announces DFU Joint Investigational Partnership with HyperMed
SUWANEE, GA, July 11, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a partnership with HyperMed in Memphis, TN to sponsor a continuing clinical investigation on Diabetic Foot Ulcers (DFUs). This investigational work is expected to begin in A
Read more →SNWVSANUWAVE Announces Third Quarter Attendance at Eight Medical Conferences
SUWANEE, GA. , June 28, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) SANUWAVE is pleased to announce that since receiving clearance from the FDA in late December 2017, its presence has been increasing in the medical device field through attendance at various trade
Read more →SNWVSANUWAVE Signs MOU for Exclusive Joint Venture with FKS in Southeast Asia
SUWANEE, GA, June 26, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a signed Joint Venture (JV) agreement with FKS, a JohnFK Medical company in Southeast Asia. The first of two exclusivity fees have been received with a second scheduled for
Read more →SNWVSANUWAVE Signs Joint Venture Partnership with Tarbaca for 3 Countries in Central America
SUWANEE, GA, June 26, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce the execution of a binding term sheet for a Joint Venture (JV) with Tarbaca Lightning, the distribution company of Latin America Pharma Supply Inc. The JV will cover Costa Ri
Read more →SNWVSANUWAVE Hires Shri Parikh as President for Global Healthcare Division
SUWANEE, GA, June 04, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce that Shri Parikh has joined SANUWAVE Health effective May 31, 2018 as President of our Healthcare division. Shri most recently joins us from Molnlycke Health Care where he he
Read more →SNWVSANUWAVE Hires Shri Parikh as President for Global Healthcare Division SUWANEE, GA, JUNE 4, 2018 - SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce that Shri Parikh has joined SANUWAVE Hea
SANUWAVE Hires Shri Parikh as President for Global Healthcare SUWANEE, GA, JUNE 4, 2018 - SANUWAVE Health, Inc. (OTCQB: SNWV) is excited to announce that Shri Parikh has joined SANUWAVE Health effective May 31, 2018 as President of our Healthcare division. Shri most recently
Read more →SNWVSANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update
SUWANEE, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) reported financial results for the three months ended March 31, 2018 with the SEC on Tuesday, May 15, 2018 and will provide a business update on a conference call today, May 16, 2018 at 9:00 a.m. Ea
Read more →SNWVSANUWAVE HEALTH REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS FIRST QUARTER FINANCIAL AND PROVIDES A BUSINESS UPDATE SUWANEE, GA, May 16, 2018 SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three months ended March 31, 2018 with the SEC on Tuesday, May 15, 2018 and will provide a business
Read more →SNWVSANUWAVE Health to Hold First Quarter 2018 Financial Results and Business Update Call on Wednesday, May 16, 2018
SUWANEE, GA, May 15, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2018 shortly. The Company will host a conference call on Wednesday, May 16, 2018, beginning at
Read more →SNWVSANUWAVE Announces AMBIENSYS SRL as Distributor for dermaPACE in Romania
SUWANEE, GA, May 09, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has appointed AMBIENSYS SRL as the distributor for the dermaPACE® System in Romania. The expected revenue from this agreement will be north of $400,000 over the next
Read more →SNWVSANUWAVE joins MenaCare as Territory Sales Manager for Sourcing and Screening of Potential Partners and Access to Clinical Trial Participation in the Middle East
SUWANEE, GA, April 25, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will join MenaCare as the Territory Sales Manager for sourcing and screening of potential distributors and access to clinical trial participation for SANUWA
Read more →SNWVSANUWAVE Announces Corporate Membership With Wounds Canada, Participation in the 2018 Spring Conferences, and Poster Acceptance at CAET
SUWANEE, GA, April 18, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has become a corporate member of Wounds Canada. Established in 1995, Wounds Canada (Canadian Association of Wound Care) is a non-profit organization dedicated to the
Read more →SNWVSANUWAVE Health, Inc. Announces the Eighth “SHOCK THIS” Blog
SUWANEE, GA, April 12, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB: SNWV) announces another installment of their blog, SHOCK THIS on its website www.sanuwave.com. The eighth blog is titled "Microcirculation Connection with Shock Wave Stimulation - A Personal Perspectiv
Read more →SNWVSANUWAVE Announces Selection to Exhibit in the New Product Showcase at SAWC in Charlotte, April 25-29, 2018
SUWANEE, GA, April 11, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company’s flagship wound care device, the dermaPACE® System, has been selected to be included in the New Product Showcase at SAWC (Symposium on Advanced Wound Care)
Read more →SNWVSANUWAVE Announces Attendance and Exhibition at SAWC; Visit Us at Booth Number 108
SUWANEE, GA, April 10, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at SAWC (Symposium on Advanced Wound Care) in Charlotte, NC on April 25 – 29, 2018. This will be SANUWAVE’s first opportunity to present their
Read more →SNWVSANUWAVE Health Reports 2017 Financial Results and Provides a Business Update
SUWANEE, Ga., March 29, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) reported financial results for the year ended December 31, 2017 with the SEC on Thursday, March 29, 2018 and provided a business update. The Company will also host a conference call today, March
Read more →SNWVSANUWAVE Will Have Four Podium Presentations as New Clinical Research at EWMA in Poland in May 2018
Meet the Experts at SANUWAVE Booth on May 10th, 2 - 4 pm SUWANEE, GA, March 27, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that during its participation at the European Wound Management Association (EWMA) Conference in Krakow, Poland on M
Read more →SNWVSanuwave Health to Hold 2017 Financial Results and Business Update Call on Thursday, March 29, 2018
SUWANEE, GA, , March 23, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the year ended December 31, 2017, on March 29, 2018. The Company will also host a conference call on Thursday, March 29, 201
Read more →SNWVSANUWAVE Announces a New "SHOCK THIS" Blog
SUWANEE, GA, March 20, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) announces another installment of their blog, SHOCK THIS on its website, www.sanuwave.com. As with the previous blogs, this seventh installment is from SANUWAVE's head of Research and Development
Read more →SNWVSANUWAVE Takes Next Step in Wound Care Expansion
DERMAPACE TECHNOLOGY SUGGESTS PROMISING OUTCOMES OF ACOUSTIC PRESSURE SHOCKWAVE TREATMENT FOR VENOUS LEG ULCERS (VLU) GLOBAL VLU MARKET SIZE SIMILAR TO DFU SUWANEE, GA, March 08, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology compan
Read more →SNWVSANUWAVE Announces First Shipments of the dermaPACE System in the U.S. Market
SUWANEE, GA, March 02, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the first product shipments in the U.S. market of the company’s dermaPACE®System occurred this week. Since receiving FDA clearance for the dermaPACE System for the trea
Read more →SNWVSANUWAVE Health, Inc., CEO Kevin Richardson Returns to Uptick Newswire’s “Stock Day” with Everett Jolly to Discuss Recent Accomplishments
PHOENIX, Feb. 21, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) ("the Company"), today announced CEO Kevin Richardson’s interview on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. “SANUWAVE Health is an exciting company, with a skilled management team th
Read more →SNWVSANUWAVE ANNOUNCES STRATEGIC PARTNERSHIP WITH PREMIER SHOCKWAVE; DERMAPACE ENTERS VA, INDIAN HEALTH SERVICES, AND MILITARY BASE MARKET; REVENUES EXPECTED TO OCCUR IMMEDIATELY SUWANEE, GA, FEBRUARY 1
SANUWAVE ANNOUNCES STRATEGIC PARTNERSHIP WITH PREMIER DERMAPACE ENTERS VA, INDIAN HEALTH SERVICES, AND MILITARY BASE REVENUES EXPECTED TO OCCUR IMMEDIATELY SUWANEE, GA, FEBRUARY 13, 2018 - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a partnership agreement has
Read more →SNWVSANUWAVE SIGNS $1 MILLION EQUIPMENT FINANCING LINE WITH NFS LEASING SUWANEE, GA, FEBRUARY 12, 2018 - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has signed a one mill
SANUWAVE SIGNS $1 MILLION EQUIPMENT FINANCING LINE WITH NFS SUWANEE, GA, FEBRUARY 12, 2018 - SANUWAVE Health, Inc. (OTCQB: pleased to announce that the Company has signed a one million dollar equipment financing lease agreement with NFS Leasing, Inc. This agreement will enabl
Read more →SNWVSANUWAVE Announces Strategic Partnership With Premier Shockwave; Dermapace Enters VA, Indian Health Services, and Military Base Market; Revenues Expected to Occur Immediately
SUWANEE, GA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a partnership agreement has been reached with Premier Shockwave Wound Care, Inc. and Premier Shockwave, Inc. (collectively “Premier”). The agreement will cover the Veteran’s
Read more →SNWVSANUWAVE Signs $1 Million Equipment Financing Line With NFS Leasing
SUWANEE, GA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has signed a one million dollar equipment financing lease agreement with NFS Leasing, Inc. This agreement will enable SANUWAVE to begin placing the dermaPAC
Read more →SNWVSANUWAVE Announces Exhibition at Wounds Canada 2018 Spring Conference
SUWANEE, GA, Feb. 07, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at Wounds Canada 2018 Spring Conference in Winnipeg, Manitoba on 11 -12 May 2018. SANUWAVE cordially invites you to visit us in our booth. Woun
Read more →SNWVSANUWAVE Announces First Time Exhibition at EWMA in Poland in May 2018
SUWANEE, GA, Feb. 02, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at EWMA (European Wound Management Association) in Krakow, Poland on May 9 – 11, 2018. This will be a great opportunity to re-invigorate our fla
Read more →SNWVSanuwave Receives U.s. Patent for the Use of Shock Waves in Cleaning and Grooming of Water Submerged Structures
Suwanee, GA., Feb. 01, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), announced today the receipt of U.S. Pat. No. 9,840,313 from the U.S. Patent and Trademark Office entitled “Cleaning and Grooming Water Submerged Structures Using Acoustic Pressure Shock Waves” th
Read more →SNWVSANUWAVE HEALTH TO PRESENT AT THE 2018 BIO CEO & INVESTOR CONFERENCE
SUWANEE, GA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a shock wave technology company, announced today that Kevin A. Richardson II, SANUWAVE’s Chairman of the board and Acting Chief Executive Officer will present at the 2018 Bio CEO & Investor Confer
Read more →SNWVSanuwave Health to Participate at 2018 Anti-Biofilm Technologies Conference in Washington DC
SUWANEE, GA, Jan. 26, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), announced today that the Company’s CEO and Board of Directors Chairman, Kevin A. Richardson II will be in attendance at the Anti-Biofilm Technologies: Pathways to Product Development Conference i
Read more →SNWVSANUWAVE Announces Exhibition at SAWC Commercialization of dermaPACE Has Begun Visit us at Booth Number 108
SUWANEE, Ga., Jan. 19, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) is pleased to announce that the company will exhibit, SAWC (Symposium on Advanced Wound Care) in Charlotte, NC on April 25 – 29, 2018. This will be SANUWAVE’s first opportunity to present their fla
Read more →SNWVSanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.
SUWANEE, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the U.S. Food and Drug Administration (FDA) has issued its decision on the de novo submission for the dermaPACE® System. Their decision, dated December 28, 2017, permits the mar
Read more →SNWVSANUWAVE Health to Hold Call to Discuss FDA Approval Letter on Tuesday, January 2, 2018
SUWANEE, GA, Dec. 29, 2017 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company has received notice from the United States Food and Drug Administration permitting the marketing of the dermaPACE® system for the treatment of Diabetic Foot Ulcers
Read more →SNWVSANUWAVE HEALTH REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS THIRD QUARTER FINANCIAL AND PROVIDES A BUSINESS UPDATE SUWANEE, GA, November 20, 2017 SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2017 on November 14 2017 and will provide a business
Read more →SNWVSANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update
SUWANEE, GA--(Marketwired - Nov 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2017 on November 14 2017 and will provide a business update on a conference call at 10:00AM Eastern Time on Tuesday, Novemb
Read more →SNWVSANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care
SUWANEE, GA--(Marketwired - Nov 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned Clinical and Science Symposium on Advanced Wound Care to be held on December 8 and 9, 2017, in Atlanta, GA. This event will gather SANUWAVE's clinical researchers
Read more →SNWVSANUWAVE Health to Hold Third Quarter 2017 Financial Results and Business Update Call on Tuesday, November 21, 2017
SUWANEE, GA--(Marketwired - Nov 13, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2017 on November 14, 2017. The Company will host a conference call on Tuesday, November 21, 2
Read more →SNWVSANUWAVE Health to Host Conference Call to Provide Update on International Activity on Thursday, September 28, 2017
SUWANEE, GA--(Marketwired - Sep 25, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Thursday, September 28, 2017, beginning at 9:00AM Eastern Time, to provide a business update on international activity and answer questi
Read more →SNWVSANUWAVE Health to Attend Upcoming Symposium on Advanced Wound Care (SAWC)
SUWANEE, GA--(Marketwired - Sep 21, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned attendance at the Symposium on Advanced Wound Care/Fall (SAWC/Fall), October 20 - 22, 2017 in Las Vegas, NV. The semi-annual SAWC meeting is the premier interdisc
Read more →SNWVSANUWAVE HEALTH REPORTs SECOND QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE SUWANEE, GA, August 14 , 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV) , today reported financial results for the
SANUWAVE HEALTH REPORTs SECOND QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE SUWANEE, GA, August 14, 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and six months ended June 30, 2017 and provided a business update. The Comp
Read more →SNWVSANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update
SUWANEE, GA--(Marketwired - Aug 14, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and six months ended June 30, 2017 and provided a business update. The Company will host a conference call at 10:30AM Eastern Time on Tuesday, August 15
Read more →SNWVSANUWAVE Health to Hold Second Quarter 2017 Financial Results and Business Update Call on Tuesday, August 15, 2017
SUWANEE, GA--(Marketwired - Aug 11, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the second quarter ended June 30, 2017 on August 14, 2017. The Company will also host a conference call on Tuesday, August 15, 2017
Read more →SNWVSANUWAVE Health Announces Extension of HealthTronics Promissory Notes
SUWANEE, GA--(Marketwired - Aug 3, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced it has entered into a third amendment to certain provisions of the two promissory notes dated August 1, 2005 between the Company and HealthTronics, Inc. with an aggregate outstanding pr
Read more →SNWVSANUWAVE HEALTH announces
SANUWAVE HEALTH announces EXTENSION OF HEALTHTRONICS PROMISSORY NOTES SUWANEE, GA, August 3, 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced it has entered into a third amendment to certain provisions of the two promissory notes dated August 1, 2005 between the Compan
Read more →SNWVSANUWAVE Health Issues a New "SHOCK THIS" Blog
SUWANEE, GA--(Marketwired - Aug 2, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces a new installment of their blog, SHOCK THIS on its website www.sanuwave.com. Similar to the prior ones, this post is from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, and
Read more →SNWVSANUWAVE HEALTH APPOINTS maj-britt kaltoft TO ITS board of directors; extensive international and strategic partnership strength added SUWANEE , GA, JUNE 16, 2017 - SANUWAVE Health, Inc. (OTCQB: SNW
SANUWAVE HEALTH APPOINTS maj-britt kaltoft TO ITS board of directors; extensive international and strategic partnership strength added SUWANEE, GA, JUNE 16, 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Maj-Britt Kaltoft to its Board of Directors.
Read more →SNWVSANUWAVE Health, Inc. Announces the Latest "Shock This" Blog
SUWANEE, GA--(Marketwired - Jun 27, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces another installment of their blog, SHOCK THIS on its website www.sanuwave.com. As the previous ones, this post is from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, and is
Read more →SNWVSANUWAVE Health Appoints Maj-Britt Kaltoft to its Board of Directors; Extensive International and Strategic Partnership Strength Added
SUWANEE, GA--(Marketwired - Jun 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Maj-Britt Kaltoft to its Board of Directors. Dr. Kaltoft brings 20 years of international specialization in development and successful execution of business developm
Read more →SNWVSANUWAVE Health Appoints Colonel Dr. Patrick Sesto to Its Medical and Science Advisory Board
SUWANEE, GA--(Marketwired - Jun 15, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of retired Colonel Dr. Patrick Sesto to the Company's Medical and Science Advisory Board. Dr. Sesto served 27 years active duty as an officer in the US Army utilizing h
Read more →SNWVSANUWAVE Health to Present at the 2017 Marcum Microcap Conference
SUWANEE, GA--(Marketwired - Jun 12, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer will present at the 2017 Marcum Microcap Conference, being he
Read more →SNWVSANUWAVE Health, Inc. Announces the Third Installment of "SHOCK THIS" Blog
SUWANEE, GA--(Marketwired - Jun 7, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces the third installment of their blog, SHOCK THIS on its website www.sanuwave.com. This post is from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, and it is titled "Shock Wav
Read more →SNWVSANUWAVE Health Announces Shock Wave Scientific Program in Milan, Italy Conducted by Medical Advanced Technologies, 26 May, 2017
SUWANEE, GA--(Marketwired - May 23, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company's exclusive distributor in Italy, Medical Advanced Technologies S.R.L. (MATEK) is sponsoring a one day scientific program to be conducted in Milan, Italy on May
Read more →SNWVSANUWAVE HEALTH REPORTs FIRST QUARTER FinANCIAL RESULTS AND PROVIDes A
SANUWAVE HEALTH REPORTs FIRST QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE SUWANEE, GA, May 16, 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three months ended March 31, 2017 and provided a business update. The Company will ho
Read more →SNWVSANUWAVE Health to Hold First Quarter 2017 Financial Results and Business Update Call on Tuesday, May 16, 2017
ALPHARETTA, GA--(Marketwired - May 12, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2017 on May 15, 2017. The Company will also host a conference call on Tuesday, May 16, 2017, b
Read more →SNWVSanuwave Health Reports Record Revenue in 2016 and Provides a Business Update
SUWANEE, GA--(Marketwired - Apr 4, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the year ended December 31, 2016 with the SEC on Friday, March 31, 2017 and today provided a business update. The Company will host a conference call today, April 4, 2017
Read more →SNWVSANUWAVE HEALTH REPORTS record revenue in 2016 AND PROVIDES A
SANUWAVE HEALTH REPORTS record revenue in 2016 AND PROVIDES A BUSINESS UPDATE SUWANEE, GA, April 4, 2017 - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the year ended December 31, 2016 with the SEC on Friday, March 31, 2017 and today provided a business up
Read more →SNWVSANUWAVE Health to Hold 2016 Financial Results and Business Update Call on Tuesday, April 4, 2017
SUWANEE, GA--(Marketwired - Mar 31, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will release financial results for the year ended December 31, 2016, on April 4, 2017. The Company will also host a conference call on Tuesday, April 4, 2017, beginni
Read more →SNWVSANUWAVE Health, Inc. Announces Latest "SHOCK THIS" Blog
SUWANEE, GA--(Marketwired - Mar 30, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces the second installment of their blog, SHOCK THIS on its website www.sanuwave.com. This post will be from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, titled "Shock Wave's
Read more →SNWVSANUWAVE Health, Inc. Launches "SHOCK THIS" Blog
SUWANEE, GA--(Marketwired - Feb 23, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) announces the launch of the blog, SHOCK THIS on its website www.sanuwave.com. The initial post will be from SANUWAVE's head of Research and Development, Dr. Iulian Cioanta, titled "What is a shockwave
Read more →SNWVSANUWAVE Health Achieves High End of Revenue Guidance for Q4 2016
SUWANEE, Ga., Jan. 26, 2017 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that they achieved revenue in a range of $640,000 - $650,000 for its fourth quarter ending December 31, 2016. SANUWAVE had previously announced expectations of $450,000 - $650,000 o
Read more →SNWVSANUWAVE Issued U.S. Patent for a Shock Wave Applicator Construction With Movable Electrode
SUWANEE, Ga., Jan. 24, 2017 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 9,522,011, titled “Shock Wave Applicator with Movable Electrode” that has an expiration date o
Read more →SNWVSANUWAVE HEALTH REPORTs THIRD QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE SUWANEE , GA, November 8 , 2016 - SANUWAVE Health, Inc. (OTCQB: SNWV) , today reported financial results for th
SANUWAVE HEALTH REPORTs THIRD QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE SUWANEE, GA, November 8, 2016 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and nine months ended September 30, 2016 and provided a business update. Th
Read more →SNWVSANUWAVE Receives Its First Canadian Patent for the Energy Industry Regarding the Use of Shock Waves in Hydraulic Fracturing for Oil Recovery
SUWANEE, Ga., Sept. 15, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today received Canadian Pat. No. 2,909,661 from the Canadian Intellectual Property Office entitled “Apparatuses and Methods for Generating Shock Waves for Use in the Energy Industry” that has a p
Read more →SNWVSANUWAVE Health Reports Record Year to Date Order Book for orthoPACE and dermaPACE – Up 280% Over 2015
SUWANEE, Ga., Aug. 30, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today reported a record order book for the 2016 year with 45 firm orders for the Company’s orthoPACE® and dermaPACE® Systems. This is up 280% from the 16 total orders for the same systems in all o
Read more →SNWVSANUWAVE HEALTH REPORTs SECOND QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE ALPHARETTA, GA, August 15 , 2016 - SANUWAVE Health, Inc. (OTCQB: SNWV) , today reported financial results for
SANUWAVE HEALTH REPORTs SECOND QUARTER FinANCIAL RESULTS AND PROVIDes A BUSINESS UPDATE ALPHARETTA, GA, August 15, 2016 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and six months ended June 30, 2016 and provided a business update. The C
Read more →SNWVSANUWAVE Health Submits de novo Petition for FDA Review and Classification of the dermaPACE System to Treat Diabetic Foot Ulcers
ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) a de novo petition requesting Agency review and classification of the dermaPACE System for treating Diabetic
Read more →SNWVSanuwave Health Announces Second Amendment and Extension of Promissory Notes
ALPHARETTA, Ga., Aug. 05, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced it has entered into a second amendment to certain provisions of the two promissory notes dated August 1, 2005 between the Company and HealthTronics, Inc. with an aggregate outsta
Read more →SNWVSANUWAVE Health to Hold Second Quarter 2016 Financial Results and Business Update Call on Monday, August 15, 2016
ALPHARETTA, Ga., Aug. 01, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the second quarter ended June 30, 2016, on August 15, 2016. The Company will also host a conference call on Monday, August 15
Read more →SNWVSANUWAVE Health to Showcase Its Shock Wave Technology at the 2016 Biofilm Science and Technology Meeting
ALPHARETTA, Ga., July 18, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), announced today that the Company will have a podium presentation at the Center for Biofilm Engineering’s 2016 Biofilm Science and Technology Meeting held at Montana State University in Bozeman,
Read more →SNWVSANUWAVE Health to Hold First Quarter 2016 Financial Results and Business Update Call on Monday, MAY 16, 2016
ALPHARETTA, Ga., May 06, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2016, after the markets close on May 13, 2016. The Company will also host a conference call
Read more →SNWVSANUWAVE Health Appoints Orthopaedic and Podiatric Shockwave Executive, A. Michael Stolarski, to its Board
ALPHARETTA, Ga., April 19, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the appointment of A. Michael Stolarski to the Company’s Board of Directors. Mr. Stolarski has 20 years of experience at multiple levels in the orthopedic, podiatric and urolo
Read more →SNWVSANUWAVE HEALTH APPOINTS ORTHOPAEDIC and PODIATRIC SHOCKWAVE EXECUTIVE, a. mICHAEL sTOLARSKI
SANUWAVE HEALTH APPOINTS ORTHOPAEDIC and PODIATRIC SHOCKWAVE EXECUTIVE, a. mICHAEL sTOLARSKI, TO ITS BOARD ALPHARETTA, GA, April 19, 2016 - SANUWAVE Health, Inc. (OTCBB: SNWV) today announced the appointment of A. Michael Stolarski to the Company's Board of Directors. Mr. Stolar
Read more →SNWVSANUWAVE Health Reports 2015 Financial Results and Provides a Business Update
ALPHARETTA, Ga., March 30, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), today reported financial results for the year ended December 31, 2015 and provided a business update. The Company will host a conference call tomorrow, March 31, 2016, at 10:00 a.m. Eastern Ti
Read more →SNWVSANUWAVE HEALTH REPORTS 2015 FinANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS 2015 FinANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ALPHARETTA, GA, March 30, 2016 - SANUWAVE Health, Inc. (OTCBB: SNWV), today reported financial results for the year ended December 31, 2015 and provided a business update. The Company will host a conf
Read more →SNWVSANUWAVE Receives U.S. Patent for Novel Electrode Design to Increase Useful Life of Electrohydraulic Shock Wave Devices
ALPHARETTA, Ga., March 29, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), announced today the receipt of U.S. Patent number 9,198,825 from the U.S. Patent and Trademark Office entitled “Increase Electrode Life in Devices Used for Extracorporeal Shockwave Therapy (ES
Read more →SNWVSANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers
ALPHARETTA, Ga., March 24, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) (www.sanuwave.com), today announced positive combined 24-week data from the Company’s pivotal double-blinded, randomized Phase III, Investigational Device Exemption (IDE) clinical trials compar
Read more →SNWVSANUWAVE Closes $1. 5 MILLION EQUITY OFFERING ALPHARETTA, GA, March 14 , 2016 - SANUWAVE Health, Inc. (OTCBB: SNWV) today announced it has closed an equity offering with select accredited investors
SANUWAVE Closes $1.5 MILLION EQUITY OFFERING ALPHARETTA, GA, March 14, 2016 - SANUWAVE Health, Inc. (OTCBB: SNWV) today announced it has closed an equity offering with select accredited investors raising total gross proceeds of $1.5 million. The company expects to close on an ad
Read more →SNWVSANUWAVE Receives U.S. Patent for Special Reflectors Used for Applying Pressure Shock Waves in Various Medical Treatments
ALPHARETTA, Ga., March 17, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), announced today the receipt of U.S. Patent Number 9,161,768 from the U.S. Patent and Trademark Office, entitled “Extracorporeal Pressure Shock Wave Devices with Reversed Applicators and Method
Read more →SNWVSANUWAVE Health to Attend Upcoming Trade Shows and Medical Conferences
ALPHARETTA, Ga., March 16, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the Company’s attendance schedule for upcoming 2016 Spring and Summer medical device shows and medical conferences. Korea International Medical and Hospital Equipment Show (KIM
Read more →SNWVSANUWAVE Health to Hold 2015 Financial Results and Business Update Call on Thursday, March 31, 2016
ALPHARETTA, Ga., March 15, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the year ended December 31, 2015, after the markets close on March 30, 2016. The Company will also host a conference call on
Read more →SNWVSANUWAVE Closes $1.5 Million Equity Offering
ALPHARETTA, Ga., March 14, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced it has closed an equity offering with select accredited investors raising total gross proceeds of $1.5 million. The company expects to close on an additional amount under the sa
Read more →SNWVSANUWAVE Health Provides Positive Fourth Quarter Business Update
ALPHARETTA, Ga., Dec. 15, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today reported positive business developments leading to a strong outlook for its fourth quarter ending December 31, 2015. “The positive actions taken during 2015 have positioned SANUWAVE for a
Read more →SNWVSANUWAVE Health Appoints Lisa Sundstrom as Chief Financial Officer
ALPHARETTA, Ga., Dec. 14, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today announced that Lisa Sundstrom, 46, has been promoted to Chief Financial Officer. Ms. Sundstrom, was formerly interim Chief Financial Officer as of
Read more →SNWVSANUWAVE HEALTH REPORTS THIRD QUARTER FinANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS THIRD QUARTER FinANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ALPHARETTA, GA, November 12, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and nine months ended September 30, 2015 and provided a business update
Read more →SNWVSANUWAVE Health to Hold Third Quarter 2015 Financial Results and Business Update Call on Friday, November 13, 2015
ALPHARETTA, Ga., Nov. 5, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the third quarter ended September 30, 2015, after the markets close on November 12, 2015. The Company will also host a confere
Read more →SNWVSANUWAVE Health to Present at the 2015 SEETHRUEQUITY Microcap Investor Forum
ALPHARETTA, Ga., Nov. 3, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer, and Lisa Sundstrom, SANUWAVE's Interim Chief Financial
Read more →SNWVSANUWAVE Health Releases dermaPACE Clinical Trial Top Line Data and Preliminary Data Analysis Results
ALPHARETTA, Ga., Oct. 8, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced top line and preliminary data analysis from the Company's pivotal Phase III, Investigational Device Exemption (IDE) supplemental clinical trial comparing the rates of 100% wound c
Read more →SNWVSANUWAVE Health to Present at the 2015 Aegis Growth Conference
ALPHARETTA, Ga., Oct. 1, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer, and Lisa Sundstrom, SANUWAVE's Interim Chief Financial
Read more →SNWVSANUWAVE Receives U.S. Patent for Cleaning and Tenderizing Animal Meat With Shock Waves
ALPHARETTA, Ga., Sept. 30, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), announced today the receipt of U.S. Patent Number 9,095,632 from the U.S. Patent and Trademark Office entitled "Methods for Cleaning and Tenderizing Animal Meat with Shock Waves" that has a pa
Read more →SNWVSANUWAVE Health to Hold dermaPACE Clinical Trial Update Conference Call on Thursday, October 8, 2015
ALPHARETTA, Ga., Sept. 29, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will conduct a conference call to discuss top line data and preliminary data results of the data analysis on the Phase III supplemental clinical trial using the
Read more →SNWVSanuwave Receives U.S. Patent for Cleaning and Sterilization of Harvested Tissue for Implantation With Shock Waves
ALPHARETTA, Ga., Sept. 24, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), announced today the issuance of U.S. Patent Number 9,119,888 by the U.S. Patent and Trademark Office entitled "Methods for Cleaning and Sterilization of Implant Tissue Ex Vivo with Shock Waves
Read more →SNWVSANUWAVE Health Letter to Shareholders
ALPHARETTA, Ga., Sept. 17, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today released a letter to its shareholders from company Chairman of the Board and Co-CEO Kevin A. Richardson, II. Dear Fellow Shareholders, I am wri
Read more →SNWVSANUWAVE Health to Present at the Singular Research 10th Annual Uncovereds Investor Conference
ALPHARETTA, Ga., Sept. 15, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer, will present at the Singular Research 10th Annual Bes
Read more →SNWVSANUWAVE Health to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
ALPHARETTA, Ga., Sept. 8, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer, will present at the Rodman & Renshaw 17th Annual Globa
Read more →SNWVSANUWAVE Health to Present at Upcoming Financial Conferences
ALPHARETTA, Ga., Sept. 4, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today announced the Company's upcoming financial conferences schedule: Rodman & Renshaw 17th Annual Global Investment Conference: Chairman Kevin Richardson will present on Thursday, September
Read more →SNWVSANUWAVE HEALTH REPORTS SECOND QUARTER FinANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS SECOND QUARTER FinANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ALPHARETTA, GA, August 11, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the three and six months ended June 30, 2015 and provided a business update. The C
Read more →SNWVSANUWAVE Health to Hold Second Quarter 2015 Financial Results and Business Update Call on Wednesday, August 12, 2015
ALPHARETTA, Ga., Aug. 6, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the second quarter ended June 30, 2015, after the markets close on August 11, 2015. The Company will also host a conference ca
Read more →SNWVSANUWAVE Health Shareholders Approve Proposal to Amend Articles of Incorporation
ALPHARETTA, Ga., July 30, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today announced that its shareholders, by an overwhelming majority, approved the Company's proposal to amend its Articles of Incorporation at the Specia
Read more →SNWVSANUWAVE Health Encourages Stockholders to Vote on Proposal to Amend Articles of Incorporation
ALPHARETTA, Ga., July 27, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today encouraged the Company's stockholders to vote no later than tomorrow, Tuesday, July 28, 2015, their proxy on the proposal to amend the Company's A
Read more →SNWVSANUWAVE Health Announces CFO Transition
ALPHARETTA, Ga., July 20, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today announced that Barry Jenkins, Chief Financial Officer, has resigned from the Company to accept a top management position at a leading medical serv
Read more →SNWVSANUWAVE HEALTH ANNOUNCES CFO TRANSITION ALPHARETTA, GA, JULY 20, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV ) , a leading shock wave technology company, today announced that Barry Jenkins, Chief Fin
SANUWAVE HEALTH ANNOUNCES CFO TRANSITION ALPHARETTA, GA, JULY 20, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading shock wave technology company, today announced that Barry Jenkins, Chief Financial Officer, has resigned from the Company to accept a top management position a
Read more →SNWVSANUWAVE Health Presents Results Showing Effectiveness of Its Shock Wave Technology for Biofilm Removal at 2015 Biofilm Science and Technology Meeting
ALPHARETTA, Ga., July 16, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, announced today the results of two poster presentations and a laboratory demonstration at the Center for Biofilm Engineering's 2015 Biofilm Science and
Read more →SNWVSANUWAVE Health to Showcase its Shock Wave Technology at the 2015 Biofilm Science and Technology Meeting
ALPHARETTA, Ga., July 8, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a leading shock wave technology company, today announced that the Company will have poster presentations and a laboratory demonstration of its patented shock wave technology at the Center for Bi
Read more →SNWVSANUWAVE Health Provides an Update on the dermaPACE Clinical Trial
ALPHARETTA, Ga., June 30, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced the plan for completing the Company's Phase III supplemental clinical trial that used the dermaPACE for treating diabetic foot ulcers. SANUWAVE and its regulatory advisors, Musc
Read more →SNWVSANUWAVE Health PROVIDES an update on the dermaPACE Clinical trial ALPHARETTA, GA, June 30 , 201 5 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the plan for completing the Company's Phase I
SANUWAVE Health PROVIDES an update on the dermaPACE Clinical trial ALPHARETTA, GA, June 30, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the plan for completing the Company's Phase III supplemental clinical trial that used the dermaPACE for treating diabetic foot
Read more →SNWVSANUWAVE Health to Present at the 2015 Landmark Venture Forum
ALPHARETTA, Ga., June 29, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), a shockwave technology company, announced today that Kevin A. Richardson II, SANUWAVE's Chairman of the board and Chief Executive Officer, will present at the 2015 Landmark Venture Forum, hoste
Read more →SNWVSANUWAVE Health to Hold dermaPACE Clinical Trial Update Conference Call on Tuesday, June 30, 2015
ALPHARETTA, Ga., June 25, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release an update on the Phase III supplemental clinical trial using the dermaPACE for treating diabetic foot ulcers on June 30, 2015. The Company will als
Read more →SNWVSANUWAVE Receives Its First U.S. Patent for the Energy Industry Regarding the Use of Shock Waves in Hydraulic Fracturing for Oil Recovery
ALPHARETTA, Ga., June 23, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), announced today the receipt of U.S. Pat. No. 9,057,232 from the U.S. Patent and Trademark Office entitled "Apparatuses and Methods for Generating Shock Waves for Use in the Energy Industry" tha
Read more →SNWVSANUWAVE Announces Strengthening of Balance Sheet With Amendment and Extension of Promissory Notes
ALPHARETTA, Ga., June 18, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced it has entered into an amendment to certain provisions of the two promissory notes dated August 1, 2005 between the Company and HealthTronics, Inc. with an aggregate outstanding
Read more →SNWVSANUWAVE announces strengthening of balance sheet with AMENDMENT AND EXTENSION OF PROMISSORY NOTES ALPHARETTA, GA, June 18 , 201 5 - SANUWAVE Health, Inc. (OTC QB : SNWV) today announced it has ente
SANUWAVE announces strengthening of balance sheet with AMENDMENT AND EXTENSION OF PROMISSORY NOTES ALPHARETTA, GA, June 18, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced it has entered into an amendment to certain provisions of the two promissory notes dated August
Read more →SNWVSANUWAVE Health PROVIDES an update on the dermaPACE Clinical trial ALPHARETTA, GA, May 6 , 201 5 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that the independent Data Monitoring Committee
SANUWAVE Health PROVIDES an update on the dermaPACE Clinical trial ALPHARETTA, GA, May 6, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy and safety results in the
Read more →SNWVSANUWAVE Health Provides an Update on the DermaPACE Clinical Trial
ALPHARETTA, Ga., May 6, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy and safety results in the Phase III supplemental clinical trial using the der
Read more →SNWVSANUWAVE Health to Hold First Quarter 2015 Financial Results Conference Call on Thursday, May 7, 2015
ALPHARETTA, Ga., May 4, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the first quarter ended March 31, 2015, after the markets close on May 6, 2015. The Company will also host a conference call on
Read more →SNWVSANUWAVE HEALTH REPORTS 2014 FinANCIAL RESULTS AND PROVIDES A
SANUWAVE HEALTH REPORTS 2014 FinANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE ALPHARETTA, GA, March 3, 2015 - SANUWAVE Health, Inc. (OTCQB: SNWV), today reported financial results for the year ended December 31, 2014 and provided a business update. The Company will host a confe
Read more →SNWVSANUWAVE Health Reports 2014 Financial Results and Provides a Business Update
ALPHARETTA, Ga., March 3, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today reported financial results for the year ended December 31, 2014 and provided a business update. The Company will host a conference call tomorrow, March 4, 2015, at 10:00 a.m. Eastern Time
Read more →SNWVSANUWAVE Health to Hold 2014 Financial Results and Business Update Call on Wednesday, March 4, 2015
ALPHARETTA, Ga., Feb. 26, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced today that the Company will release financial results for the year ended December 31, 2014, after the markets close on March 3, 2015. The Company will also host a conference call on W
Read more →SNWVSANUWAVE Receives U.S. Patent for Medical Treatment Systems That Select and Use the Proper Ancillary Interfaces and Specific Treatment Parameters for Electronic Treatment Devices
ALPHARETTA, Ga., Feb. 25, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) announced today the receipt of U.S. Pat. No. 8,961,441 from the U.S. Patent and Trademark Office entitled, "Medical Treatment System Including an Ancillary Medical Treatment Apparatus with an As
Read more →SNWVSANUWAVE Health Signs Memoranda of Understanding With Dasman Diabetes Institute and Kuwait Life Sciences Company
Companies to Establish a Strategic Alliance and Joint Venture to Introduce the dermaPACE Device as a Preferred Treatment for Diabetic Foot Ulcers in the Gulf Cooperation Council Region SANUWAVE Receives Initial dermaPACE Device Order for the GCC ALPHARETTA, Ga., Dec. 2, 2014 (G
Read more →SNWVSANUWAVE Enrolls 130th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers
ALPHARETTA, Ga., Dec. 1, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has enrolled its 130th patient in the Phase III supplemental clinical trial using dermaPACE for treating diabetic foot ulcers (DFU's), which represents the number
Read more →SNWVSANUWAVE Health reports Third QUARTER financial results and provides a BUSiness update ALPHARETTA, GA, November 12 , 201 4 - SANUWAVE Health, Inc. (OTCQ B: SNWV ) today reported financial results fo
SANUWAVE Health reports Third QUARTER financial results and provides a BUSiness update ALPHARETTA, GA, November 12, 2014 - SANUWAVE Health, Inc. (OTCQB: SNWV) today reported financial results for the three and nine months ended September 30, 2014 and provided a business update.
Read more →SNWVSANUWAVE Health to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November 13
ALPHARETTA, Ga., Nov. 6, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the third quarter ended September 30, 2014 after the markets close on November 12, 2014. The Company will hold a conference ca
Read more →SNWVSANUWAVE Health Receives Information From the Data Monitoring Committee on the dermaPACE Clinical Trial
ALPHARETTA, Ga., Sept. 10, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the independent Data Monitoring Committee (DMC) has performed an interim analysis on the efficacy results for the first 90 patients in the Phase III supplemental clinical t
Read more →SNWVSANUWAVE Health to Hold Second Quarter 2014 Financial Results Conference Call on Thursday, August 7
ALPHARETTA, Ga., July 29, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the second quarter ended June 30, 2014 after the markets close on August 6, 2014. The Company will hold a conference call on
Read more →SNWVSANUWAVE Health Signs Strategic Agreement With Premier Shockwave to Manage OssaTron Devices
ALPHARETTA, Ga., July 22, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has signed a strategic agreement with Premier Shockwave, Inc. to manage the Company's OssaTron devices. The three year agreement with Premier Shockwave will prov
Read more →SNWVSANUWAVE Health to Present at the Newport Coast Securities 2014 National Sales & Equity Conference
ALPHARETTA, Ga., June 10, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced the Company will present at the Newport Coast Securities 2014 National Sales & Equity Conference on Friday, June 13, at the W New York Hotel in New York City. Kevin Richardson, SANUWA
Read more →SNWVSANUWAVE Health to Present at the 4th Annual Micro-Cap Invitational Conference Hosted by LD Micro
ALPHARETTA, Ga., May 30, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced the Company will present at the 4th Annual Micro-Cap Invitational Conference hosted by LD Micro on Wednesday, June 4, at the Luxe Hotel in Los Angeles, California. Kevin Richardson, SA
Read more →SNWVSANUWAVE Health to Present at the Accredited Members Spring 2014 Small Cap/Micro Cap Conference
ALPHARETTA, Ga., May 29, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced the Company will present at the Accredited Members Spring 2014 Small Cap/Micro Cap Conference on Tuesday, June 3, in Colorado Springs, Colorado. Barry Jenkins, SANUWAVE's Chief Financi
Read more →SNWVSANUWAVE Health to Present at the Third Annual Marcum MicroCap Conference
ALPHARETTA, Ga., May 23, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) announced the Company will present at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, at the Grand Hyatt Hotel in New York City. Kevin Richardson, SANUWAVE's Chairman of the board
Read more →SNWVSANUWAVE Receives U.S. Patent for Stem Cell Treatments Using Shock Wave Technology
ALPHARETTA, Ga., May 20, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today received a patent issued by the U.S. Patent and Trademark Office entitled "Use of Pressure Waves for Stimulation, Proliferation, Differentiation and Post-Implantation Viability of Stem Cell
Read more →SNWVSANUWAVE Health reports FIRST QUARTER financial results and provides a BUSiness update ALPHARETTA, GA
SANUWAVE Health reports FIRST QUARTER financial results and provides a BUSiness update ALPHARETTA, GA, May 13, 2014 - SANUWAVE Health, Inc. (OTCQB: SNWV) today reported financial results for the three months ended March 31, 2014 and provided a business update. The Company will
Read more →SNWVSANUWAVE Receives U.S. Patent for Cleaning and Sterilization of Fluids and Food Liquids With Shock Waves
ALPHARETTA, Ga., May 12, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Methods and Devices for Cleaning and Sterilization with Shock Waves." The claims of the patent (patent number 8,685,
Read more →SNWVSANUWAVE Health to Hold First Quarter 2014 Financial Results and Business Update Conference Call on Wednesday, May 14
ALPHARETTA, Ga., May 6, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the first quarter ended March 31, 2014 after the markets close on May 13, 2014. The Company will hold a conference call on Wedn
Read more →SNWVSANUWAVE Enrolls 90th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers and Achieves Minimum Required Enrollment
ALPHARETTA, Ga., April 30, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company has enrolled its 90th patient in the Phase III supplemental clinical trial using dermaPACE for treating diabetic foot ulcers (DFU's), which represents the minim
Read more →SNWVSANUWAVE Health Announces executive changes ALPHARETTA, GA
SANUWAVE Health Announces executive changes ALPHARETTA, GA, April 21, 2014 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that Joseph Chiarelli, the Company's Chief Executive Officer, is no longer employed by the Company effective April 15, 2014. Kevin A. Richardson, II,
Read more →SNWVSANUWAVE Health Announces Executive Changes
ALPHARETTA, Ga., April 21, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that Joseph Chiarelli, the Company's Chief Executive Officer, is no longer employed by the Company effective April 15, 2014. Kevin A. Richardson, II, Chairman of the Company's B
Read more →SNWVSANUWAVE Health reports 2013 financial results and provides a Clinical Trial and FUNDING update ALPHARETTA, GA
SANUWAVE Health reports 2013 financial results and provides a Clinical Trial and FUNDING update ALPHARETTA, GA, March 31, 2014 - SANUWAVE Health, Inc. (OTCQB: SNWV) today reported financial results for the year ended December 31, 2013 and provided a clinical trial and funding u
Read more →SNWVSANUWAVE Health Reports 2013 Financial Results and Provides a Clinical Trial and Funding Update
ALPHARETTA, Ga., March 31, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today reported financial results for the year ended December 31, 2013 and provided a clinical trial and funding update. The Company will host a conference call tomorrow, April 1, 2014, at 10:00
Read more →SNWVSANUWAVE Health to Hold 2013 Financial Results and Business Update Conference Call on Tuesday, April 1, 2014
ALPHARETTA, Ga., March 26, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV) today announced that the Company will release financial results for the year ended December 31, 2013 after the markets close on March 31, 2014. The Company will also host a conference call on
Read more →SNWVSANUWAVE Closes $10.1M Private Placement Led by RA Capital Management
ALPHARETTA, Ga., March 18, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced it has closed a private placement with institutional and select accredited investors raising total gross proceeds of $10.1 million. The financing was led by established life-sci
Read more →SNWVSANUWAVE Closes $10.1M Private placement Led By RA Capital Management ALPHARETTA, GA
SANUWAVE Closes $10.1M Private placement Led By RA Capital Management ALPHARETTA, GA, March 18, 2014 - SANUWAVE Health, Inc. (OTCBB: SNWV) today announced it has closed a private placement with institutional and select accredited investors raising total gross proceeds of $10.1 m
Read more →SNWVSANUWAVE Announces Agreement for Licensing and Distribution for Gulf Cooperation Council (GCC) Region
ALPHARETTA, Ga., Feb. 11, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has signed an agreement with Wirthlin, a Dentons Innovation Group Partnership (Wirthlin-Dentons), to provide strategic advisory services and to establish a joint venture
Read more →SNWVSANUWAVE Provides Update on Patient Enrollment - Over 75% Now Enrolled in Pivotal dermaPACE Clinical Trial
ALPHARETTA, Ga., Jan. 29, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that it has enrolled over seventy-five percent (75%) of the minimum required patients in the Phase III supplemental clinical trial evaluating the dermaPACE device on patients with
Read more →SNWVSANUWAVE REPORTS Third QUARTER 2013
SANUWAVE REPORTS Third QUARTER 2013 FINANCIAL RESULTS ALPHARETTA, GA, November 12, 2013 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the three and nine months ended September 30, 2013 and provided a business update. The Company will host a conferenc
Read more →SNWVSANUWAVE Reports Third Quarter 2013 Financial Results
ALPHARETTA, Ga., Nov. 12, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and nine months ended September 30, 2013 and provided a business update. The Company will host a conference call today at 10:00 a.m. Eastern Time.
Read more →SNWVSANUWAVE to Hold Third Quarter Financial Results Conference Call on Tuesday, November 12
ALPHARETTA, Ga., Nov. 7, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company will release financial results for the third quarter ended September 30, 2013 prior to the opening of the market on Tuesday, November 12, 2013. The Company will h
Read more →SNWVSANUWAVE Receives U.S. Patent for New Type of Applicators Used for Shock Wave Technology
ALPHARETTA, Ga., Oct. 17, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Extracorporeal Shock Wave Device." The claims of the patent (patent number 8,556,813) relate to a new extracorporea
Read more →SNWVSANUWAVE Provides Update on Patient Enrollment in Pivotal dermaPACE Clinical Trial
ALPHARETTA, Ga., Oct. 8, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that it has enrolled fifty percent (50%) of the minimum required patients in the Phase III supplemental clinical trial evaluating the dermaPACE device on patients with diabetic foo
Read more →SNWVSANUWAVE's orthoPACE Medical Device Receives Regulatory Approval in South Korea
ALPHARETTA, Ga., Sept. 10, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that its orthoPACE device has received official regulatory approval from the South Korean Ministry of Food and Drug Safety (MFDS - South Korea). With this approval, SANUWAVE will
Read more →SNWVSANUWAVE appoints life sciences industry executive, alan l. rubino to its board ALPHARETTA, GA
SANUWAVE appoints life sciences industry executive, alan l. rubino ALPHARETTA, GA, September 4, 2013 - SANUWAVE Health, Inc. (OTCBB: SNWV) today announced the appointment of Alan L. Rubino to the Company's Board of Directors. Mr. Rubino has more than 30 years of experience at ev
Read more →SNWVSANUWAVE Appoints Life Sciences Industry Executive, Alan L. Rubino To Its Board
ALPHARETTA, Ga., Sept. 4, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the appointment of Alan L. Rubino to the Company's Board of Directors. Mr. Rubino has more than 30 years of experience at every level of the biopharmaceutical industry, including
Read more →SNWVSANUWAVE REPORTS SECOND QUARTER 2013
SANUWAVE REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS ALPHARETTA, GA, August 14, 2013 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the three and six months ended June 30, 2013 and provided a business update. The Company will host a conference call
Read more →SNWVSANUWAVE Reports Second Quarter 2013 Financial Results
ALPHARETTA, Ga., Aug. 14, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and six months ended June 30, 2013 and provided a business update. The Company will host a conference call on Thursday, August 15 at 10:00 a.m. Eas
Read more →SNWVSANUWAVE to Hold Second Quarter Financial Results Conference Call on Thursday, August 15
ALPHARETTA, Ga., Aug. 13, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company will release financial results for the second quarter ended June 30, 2013 following the close of the market on Wednesday, August 14, 2013. The Company will hold
Read more →SNWVSANUWAVE ANNOUNCES CONVERSION OF ALL SEnior
SANUWAVE ANNOUNCES CONVERSION OF ALL SEnior SECURED NOTES ALPHARETTA, GA, August 5, 2013 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported that all of the holders of the Company's 18% senior secured convertible promissory notes voluntarily converted all of the outstanding pri
Read more →SNWVSANUWAVE Announces Conversion of All Senior Secured Notes
ALPHARETTA, Ga., Aug. 5, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that all of the holders of the Company's 18% senior secured convertible promissory notes voluntarily converted all of the outstanding principal and interest of the notes into commo
Read more →SNWVSANUWAVE Closes Public Offering
ALPHARETTA, Ga., July 25, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) announced today that it has sold approximately $1.6 million in Units, with each Unit consisting of one share of common stock and a warrant to purchase one-half share of common stock, in a public
Read more →SNWVSANUWAVE's PACE Technology Protects Tissue From Ischemia-Reperfusion Injury Common in Microsurgical Procedures
ALPHARETTA, Ga., July 15, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that pre-clinical results using the Company's patented Pulsed Acoustic Cellular Expression (PACE ) technology, which uses focused high-energy acoustic shock waves, were presented
Read more →SNWVSANUWAVE's PACE Data to be Presented at the 2013 World Congress of Microsurgery
ALPHARETTA, Ga., July 10, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that pre-clinical results using the Company's patented Pulsed Acoustic Cellular Expression (PACE ) technology, which uses focused high-energy acoustic shock waves, will be present
Read more →SNWVSANUWAVE Enrolls First Diabetic Foot Ulcer Patient in the dermaPACE Clinical Trial
ALPHARETTA, Ga., June 5, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported that the first patient has been enrolled and begun treatment in the supplemental Phase III clinical trial of the Company's dermaPACE device for treating diabetic foot ulcers. The c
Read more →SNWVSANUWAVE Reports First Quarter 2013 Financial Results
ALPHARETTA, Ga., May 14, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three months ended March 31, 2013 and provided a business update. The Company will host a conference call on Wednesday, May 15 at 10:00 a.m. Eastern Time.
Read more →SNWVSANUWAVE REPORTS FIRST QUARTER 2013
SANUWAVE REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS ALPHARETTA, GA, May 14, 2013 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the three months ended March 31, 2013 and provided a business update. The Company will host a conference call on Wednesda
Read more →SNWVSANUWAVE Completes Investigator Meeting
ALPHARETTA, Ga., May 13, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company held an investigator meeting in Atlanta, Georgia on May 10-11, 2013. The meeting served as the official kick-off of the supplemental Phase III clinical trial util
Read more →SNWVSANUWAVE Appoints Daniel M. Jorgensen as Chief Medical Officer
ALPHARETTA, Ga., May 1, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced the Company has appointed Daniel M. Jorgensen, MD, MPH, MBA as its Chief Medical Officer. Dr. Jorgensen is an accomplished physician executive with more than 15 years of experience
Read more →SNWVSANUWAVE Receives U.S. Patent to Sterilize Blood Using Its Shock Wave Technology
ALPHARETTA, Ga., April 11, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Method and Devices for Cleaning and Sterilization with Shock Waves." The claims of the patent (patent number 8,343
Read more →SNWVSANUWAVE HEALTH REPORTS 2012
SANUWAVE HEALTH REPORTS 2012 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE ALPHARETTA, GA, March 26, 2013 SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the year ended December 31, 2012, and provided a business update. Joseph Chiarelli, Chief Executi
Read more →SNWVSANUWAVE Health Reports 2012 Financial Results and Provides Business Update
ALPHARETTA, Ga., March 26, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the year ended December 31, 2012, and provided a business update. Joseph Chiarelli, Chief Executive Officer of SANUWAVE, commented, "During 2012, we made p
Read more →SNWVSANUWAVE Announces dermaPACE Regulatory Approval and Distribution Agreement in Australia and New Zealand
ALPHARETTA, Ga., March 26, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) announced today the launch of its dermaPACE wound healing system in Australia and New Zealand. dermaPACE received the Australian Therapeutic Goods Administration (TGA) approval in March 2013 to
Read more →SNWVSANUWAVE Health to Hold 2012 Financial Results and Business Update Conference Call on Wednesday, March 27
ALPHARETTA, Ga., March 21, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company will release financial results for the year ended December 31, 2012 following the close of the market on Tuesday, March 26, 2013. The Company will hold a confe
Read more →SNWVSANUWAVE HEALTH RECEIVES FULL APPROVAL FROM THE FDA TO CONDUCT THE DERMAPACE PIVOTAL CLINICAL TRIAL FDA has approved clinical study design 15 Clinical site contracts negotiated First enrollment anti
SANUWAVE HEALTH RECEIVES FULL APPROVAL FROM THE FDA TO CONDUCT THE DERMAPACE PIVOTAL CLINICAL TRIAL FDA has approved clinical study design 15 Clinical site contracts negotiated First enrollment anticipated in Q2-2013 CPC Clinical Research engaged as CRO ALPHARETTA,
Read more →SNWVSANUWAVE Health Receives Full Approval From the FDA to Conduct the dermaPACE Pivotal Clinical Trial
FDA has approved clinical study design 15 Clinical site contracts negotiated First enrollment anticipated in Q2-2013 CPC Clinical Research engaged as CRO ALPHARETTA, Ga., March 13, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today provided an update on the Com
Read more →SNWVSANUWAVE HEALTH ANNOUNCES THE APPOINTMENT OF CEO AND CLOSING OF ITS $2.0
SANUWAVE HEALTH ANNOUNCES THE APPOINTMENT OF CEO AND CLOSING OF ITS $2.0 MILLION BRIDGE FINANCING ALPHARETTA, GA, February 26, 2013 SANUWAVE Health, Inc. (OTCBB: SNWV) today announced that the Company has appointed Wall Street and healthcare industry veteran Joseph Chiarelli as
Read more →SNWVSANUWAVE Health Announces the Appointment of CEO and Closing of its $2.0 Million Bridge Financing
ALPHARETTA, Ga., Feb. 26, 2013 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that the Company has appointed Wall Street and healthcare industry veteran Joseph Chiarelli as Chief Executive Officer and a Director and the closing of a $2.0 million bridge fin
Read more →SNWVSANUWAVE REPORTS THIRD QUARTER 2012
SANUWAVE REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS ALPHARETTA, GA, November 14, 2012 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the three and nine months ended September 30, 2012 and provided a business update. Kevin A. Richardson, II, Chairma
Read more →SNWVSANUWAVE Reports Third Quarter 2012 Financial Results
ALPHARETTA, Ga., Nov. 14, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and nine months ended September 30, 2012 and provided a business update. Kevin A. Richardson, II, Chairman of the Board of Directors of SANUWAVE,
Read more →SNWVSANUWAVE Announces Executive Changes and Funding Update
ALPHARETTA, Ga., Nov. 7, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that Christopher M. Cashman will be leaving as President, Chief Executive Officer and Director. Mr. Cashman will continue to serve the Company in an advisory role. Barry J. Jenkin
Read more →SNWVSANUWAVE Reports Second Quarter 2012 Financial Results and Provides a Business Update
ALPHARETTA, Ga., Aug. 8, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today reported financial results for the three and six months ended June 30, 2012 and provided a business update. Christopher M. Cashman, President and CEO of SANUWAVE, said, "I am very pleased
Read more →SNWVSANUWAVE REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE Company to Hold Conference Call at 11:00 a.m. Eastern Time on Thursday, August 9 ALPHARETTA, GA
SANUWAVE REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE Company to Hold Conference Call at 11:00 a.m. Eastern Time on Thursday, August 9 ALPHARETTA, GA, August 8, 2012 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results for the t
Read more →SNWVSANUWAVE to Hold Second Quarter 2012 Financial Results Conference Call on Thursday, August 9
ALPHARETTA, Ga., Aug. 6, 2012 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV), an emerging regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, muscu
Read more →SNWVSANUWAVE REPORTS 2011
SANUWAVE REPORTS 2011 FINANCIAL RESULTS AND PROVIDES UPDATE ON DERMAPACE FDA STATUS ALPHARETTA, GA, March 14, 2012 - SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results and accomplishments for the year ended December 31, 2011, and provided an update on the U.S.
Read more →SNWVSANUWAVE Health, Inc. Barry Jenkins, CFO Bernie Laurel, VP of Sales and Marketing 678-578-0103 investorrelations@sanuwave.com Lippert/Heilshorn & Associates Anne Marie Fields (Investors) 212-838-3777 afields@lhai.com Mac
SANUWAVE UPDATES ON FDA REVIEW OF DERMAPACE PREMARKET APPROVAL APPLICATION ALPHARETTA, GA, December 21, 2011 - SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activa
Read more →SNWVSANUWAVE Health, Inc. Lippert/Heilshorn & Associates Barry Jenkins, CFO Anne Marie Fields (Investors) Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com investorrelations@sanuwave.com Mac
SANUWAVE Health, Inc. Lippert/Heilshorn & Associates Barry Jenkins, CFO Anne Marie Fields (Investors) Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com investorrelations@sanuwave.com Mackenzie Mills (Media) 212-838-3777 SANUWAVE APPOINTS MEDICA
Read more →SNWVSANUWAVE Health, Inc. Barry Jenkins, CFO Bernie Laurel, VP of Sales and Marketing 678-578-0103 investorrelations@sanuwave.com Lippert/Heilshorn & Associates Anne Marie Fields 212-838-3777 afields@lhai.com FOR IMMEDIATE R
SANUWAVE ANNOUNCES POSITIVE 24-WEEK DATA FROM ITS PIVOTAL TRIAL WITH DERMAPACE FOR THE TREATMENT OF DIABETIC FOOT ULCERS Results Clearly Demonstrate dermaPACE Safely Heals Diabetic Foot Ulcers Conference Call with Principal Investigators Begins at 11:00 a.m. Eastern Time Today
Read more →SNWVSANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com investorrelations@sanuwave.com FOR IMMEDIATE REL
SANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com investorrelations@sanuwave.com SANUWAVE HEALTH REPORTS 2010 FINANCIAL RESULTS ALPHARETTA, GA, March
Read more →SNWVSANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com FOR IMMEDIATE RELEASE SANUWAVE HEALTH REPORTS TH
SANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com HEALTH REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Patient Follow-Up Complet
Read more →SNWVSANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com FOR IMMEDIATE RELEASE SANUWAVE HEALTH REPORTS SE
SANUWAVE Health, Inc. Lippert/Heilshorn Associates Barry Jenkins, CFO Anne Marie Fields Bernie Laurel, VP of Sales and Marketing 212-838-3777 678-578-0103 afields@lhai.com SANUWAVE HEALTH REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Launched orthoP
Read more →SNWVSANUWAVE, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS Years Ended
SANUWAVE, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS Years Ended December 31, 2008 and 2007 SANUWAVE, INC. AND SUBSIDIARIES Pages Report of Independent Registered Accounting Firm 1 Consolidated Financial Statements Balance Sheets 2 Statements of Inco
Read more →Competitive Position
How SNWV ranks across every disease it competes inCompetitive Position is a premium feature
See how SNWV ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial